activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	6364785	CHEMBL1832853	Binding affinity to first bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1ccc2c(c1)CN(C)C(=O)N2		CHEMBL1828978	=	Delta Tm	degrees C	7.2	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	7.2
	6364785	CHEMBL1832853	Binding affinity to first bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1ccc2c(c1)CN(C)C(=O)N2		CHEMBL1828978	=	Delta Tm	degrees C	7.2	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	7.2
	6364786	CHEMBL1832853	Binding affinity to first bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1ccccc1		CHEMBL1828979	=	Delta Tm	degrees C	1.6	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	1.6
	6364787	CHEMBL1832853	Binding affinity to first bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CC(=O)c1cccc(-c2c(C)noc2C)c1		CHEMBL1828980	=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	6364788	CHEMBL1832853	Binding affinity to first bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cccc(-c2c(C)noc2C)c1		CHEMBL1828981	=	Delta Tm	degrees C	2.7	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.7
	6364789	CHEMBL1832853	Binding affinity to first bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1cccc(C(C)O)c1		CHEMBL1828982	=	Delta Tm	degrees C	5.3	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	5.3
	6364790	CHEMBL1832853	Binding affinity to first bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOC(=O)c1cc(OCC)cc(-c2c(C)noc2C)c1		CHEMBL1828983	=	Delta Tm	degrees C	3.6	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	3.6
	6364791	CHEMBL1832853	Binding affinity to first bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(C(=O)O)cc(-c2c(C)noc2C)c1		CHEMBL1828984	=	Delta Tm	degrees C	2.2	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.2
	6364792	CHEMBL1832853	Binding affinity to first bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(C(C)=O)cc(-c2c(C)noc2C)c1		CHEMBL1828985	=	Delta Tm	degrees C	4.8	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	4.8
	6364793	CHEMBL1832853	Binding affinity to first bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(-c2c(C)noc2C)cc(C(C)O)c1		CHEMBL1828986	=	Delta Tm	degrees C	8.5	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.5
	6364794	CHEMBL1832852	Binding affinity to second bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1ccc2c(c1)CN(C)C(=O)N2		CHEMBL1828978	=	Delta Tm	degrees C	6.8	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	6.8
	6364795	CHEMBL1832852	Binding affinity to second bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1ccccc1		CHEMBL1828979	=	Delta Tm	degrees C	1.9	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	1.9
	6364796	CHEMBL1832852	Binding affinity to second bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CC(=O)c1cccc(-c2c(C)noc2C)c1		CHEMBL1828980	=	Delta Tm	degrees C	2.9	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.9
	6364797	CHEMBL1832852	Binding affinity to second bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cccc(-c2c(C)noc2C)c1		CHEMBL1828981	=	Delta Tm	degrees C	4.2	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	4.2
	6364798	CHEMBL1832852	Binding affinity to second bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1cccc(C(C)O)c1		CHEMBL1828982	=	Delta Tm	degrees C	6.5	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	6.5
	6364799	CHEMBL1832852	Binding affinity to second bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOC(=O)c1cc(OCC)cc(-c2c(C)noc2C)c1		CHEMBL1828983	=	Delta Tm	degrees C	3.8	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	3.8
	6364800	CHEMBL1832852	Binding affinity to second bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(C(=O)O)cc(-c2c(C)noc2C)c1		CHEMBL1828984	=	Delta Tm	degrees C	2.6	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.6
	6364801	CHEMBL1832852	Binding affinity to second bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(C(C)=O)cc(-c2c(C)noc2C)c1		CHEMBL1828985	=	Delta Tm	degrees C	6.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	6.0
	6364802	CHEMBL1832852	Binding affinity to second bromodomain of BRD3 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(-c2c(C)noc2C)cc(C(C)O)c1		CHEMBL1828986	=	Delta Tm	degrees C	8.9	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.9
	8034556	CHEMBL1953101	Binding affinity to His-6 tagged BRD3 expressed in Escherichia coli at 100 uM after 60 mins by fluorescence anisotropic analysis	B	CC(=O)N1c2ccccc2CCC1C		CHEMBL1950955	=	Activity	%	44.0	CHEMBL1795186	Homo sapiens	Activity	%	44.0
	8034559	CHEMBL1953104	Inhibition of His-6 tagged BRD3-RD12 precoupled with biotinylated tetra-acetylated histone H4 expressed in Escherichia coli assessed as protein-protein interaction at 50 uM after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccccc2CCC1C		CHEMBL1950955	=	Inhibition	%	29.0	CHEMBL1795186	Homo sapiens	INH	%	29.0
	8034562	CHEMBL1953107	Inhibition of His-6 tagged BRD3 expressed in Escherichia coli after 60 mins by fluorescence anisotropic analysis	B	CC(=O)c1cc(-c2ccccn2)c2ccccn12		CHEMBL1950956	=	IC50	nM	6300.0	CHEMBL1795186	Homo sapiens	IC50	uM	6.3
	8034565	CHEMBL1953110	Inhibition of His-6 tagged BRD3-RD12 interaction precoupled with biotinylated tetra-acetylated histone H4 expressed in Escherichia coli after 1 hr by TR-FRET assay	B	CC(=O)c1cc(-c2ccccn2)c2ccccn12		CHEMBL1950956	=	IC50	nM	2500.0	CHEMBL1795186	Homo sapiens	IC50	uM	2.5
	8034570	CHEMBL1953101	Binding affinity to His-6 tagged BRD3 expressed in Escherichia coli at 100 uM after 60 mins by fluorescence anisotropic analysis	B	CN1Cc2ccccc2NC1=O		CHEMBL1230189	=	Activity	%	14.0	CHEMBL1795186	Homo sapiens	Activity	%	14.0
	8034573	CHEMBL1953104	Inhibition of His-6 tagged BRD3-RD12 precoupled with biotinylated tetra-acetylated histone H4 expressed in Escherichia coli assessed as protein-protein interaction at 50 uM after 1 hr by TR-FRET assay	B	CN1Cc2ccccc2NC1=O		CHEMBL1230189	=	Inhibition	%	22.0	CHEMBL1795186	Homo sapiens	INH	%	22.0
	8034576	CHEMBL1953107	Inhibition of His-6 tagged BRD3 expressed in Escherichia coli after 60 mins by fluorescence anisotropic analysis	B	CN1Cc2cc(S(=O)(=O)N3CCOCC3)ccc2N(C)C1=O		CHEMBL1950957	=	IC50	nM	30000.0	CHEMBL1795186	Homo sapiens	IC50	uM	30.0
	8034579	CHEMBL1953101	Binding affinity to His-6 tagged BRD3 expressed in Escherichia coli at 100 uM after 60 mins by fluorescence anisotropic analysis	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112	=	Activity	%	7.0	CHEMBL1795186	Homo sapiens	Activity	%	7.0
	8034582	CHEMBL1953104	Inhibition of His-6 tagged BRD3-RD12 precoupled with biotinylated tetra-acetylated histone H4 expressed in Escherichia coli assessed as protein-protein interaction at 50 uM after 1 hr by TR-FRET assay	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112	=	Inhibition	%	19.0	CHEMBL1795186	Homo sapiens	INH	%	19.0
	8034587	CHEMBL1953101	Binding affinity to His-6 tagged BRD3 expressed in Escherichia coli at 100 uM after 60 mins by fluorescence anisotropic analysis	B	CN1CCCC1=O		CHEMBL12543	<	Activity	%	5.0	CHEMBL1795186	Homo sapiens	Activity	%	5.0
	8034590	CHEMBL1953104	Inhibition of His-6 tagged BRD3-RD12 precoupled with biotinylated tetra-acetylated histone H4 expressed in Escherichia coli assessed as protein-protein interaction at 50 uM after 1 hr by TR-FRET assay	B	CN1CCCC1=O		CHEMBL12543	<	Inhibition	%	5.0	CHEMBL1795186	Homo sapiens	INH	%	5.0
	8046386	CHEMBL1958560	Binding affinity to BRD3-BD1 by isothermal titration calorimetry	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	59.5	CHEMBL1795186	Homo sapiens	Kd	nM	59.5
	8046387	CHEMBL1958559	Binding affinity to BRD3-BD2 by isothermal titration calorimetry	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	82.0	CHEMBL1795186	Homo sapiens	Kd	nM	82.0
	8046396	CHEMBL1958572	Displacement of acetylated histone peptide from BRD3-BD1,2 by FRET assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1		CHEMBL1738926	=	IC50	nM	28.4	CHEMBL1795186	Homo sapiens	IC50	nM	28.4
	8046399	CHEMBL1958565	Binding affinity to BRD3-BD1,2 by isothermal titration calorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	50.5	CHEMBL1795186	Homo sapiens	Kd	nM	50.5
	8046402	CHEMBL1958572	Displacement of acetylated histone peptide from BRD3-BD1,2 by FRET assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	IC50	nM	42.4	CHEMBL1795186	Homo sapiens	IC50	nM	42.4
	8046405	CHEMBL1958565	Binding affinity to BRD3-BD1,2 by isothermal titration calorimetry	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1		CHEMBL1738926	=	Kd	nM	46.0	CHEMBL1795186	Homo sapiens	Kd	nM	46.0
	8055845	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCC(=O)Nc2ccc(Cl)cc21		CHEMBL1958341	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055846	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCC(=S)Nc2ccc(Cl)cc21		CHEMBL1958342	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055847	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(CC)n2-c2ccc(Cl)cc21		CHEMBL1958340	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055848	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3ccccc3)n2-c2ccc(Cl)cc21		CHEMBL1958346	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055849	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3ccncc3)n2-c2ccc(Cl)cc21		CHEMBL1958343	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055850	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3cccc(OC)c3)n2-c2ccc(Cl)cc21		CHEMBL1958345	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055851	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(C)n2-c2ccc(Cl)cc21		CHEMBL1958344	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055852	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=S		CHEMBL1958335	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055853	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CC(=O)NNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=NN1C		CHEMBL1958336	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055854	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NN2C		CHEMBL1958337	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055855	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2-n2c(N)nnc21		CHEMBL1958338	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8055856	CHEMBL1958929	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2-n2c1n[nH]c2=O		CHEMBL1958339	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
Active	8055947	CHEMBL1958938	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2		CHEMBL661		Activity			CHEMBL1795186	Homo sapiens	Activity		
Active	8055948	CHEMBL1958938	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NN2C		CHEMBL1958337		Activity			CHEMBL1795186	Homo sapiens	Activity		
Active	8055949	CHEMBL1958938	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2		CHEMBL285674		Activity			CHEMBL1795186	Homo sapiens	Activity		
Active	8055950	CHEMBL1958938	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	CCOC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc1-2		CHEMBL52030		Activity			CHEMBL1795186	Homo sapiens	Activity		
Active	8055951	CHEMBL1958938	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2		CHEMBL655		Activity			CHEMBL1795186	Homo sapiens	Activity		
Active	8055952	CHEMBL1958938	Binding affinity to BRD3-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2		CHEMBL646		Activity			CHEMBL1795186	Homo sapiens	Activity		
	8056013	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCC(=O)Nc2ccc(Cl)cc21		CHEMBL1958341	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056014	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCC(=S)Nc2ccc(Cl)cc21		CHEMBL1958342	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056015	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(CC)n2-c2ccc(Cl)cc21		CHEMBL1958340	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056016	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3ccccc3)n2-c2ccc(Cl)cc21		CHEMBL1958346	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056017	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3ccncc3)n2-c2ccc(Cl)cc21		CHEMBL1958343	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056018	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3cccc(OC)c3)n2-c2ccc(Cl)cc21		CHEMBL1958345	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056019	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(C)n2-c2ccc(Cl)cc21		CHEMBL1958344	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056020	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=S		CHEMBL1958335	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056021	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CC(=O)NNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=NN1C		CHEMBL1958336	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056022	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NN2C		CHEMBL1958337	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056023	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2-n2c(N)nnc21		CHEMBL1958338	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	8056024	CHEMBL1959067	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2-n2c1n[nH]c2=O		CHEMBL1958339	<=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
Active	8056043	CHEMBL1959070	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2		CHEMBL661		Activity			CHEMBL1795186	Homo sapiens	Activity		
Active	8056044	CHEMBL1959070	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NN2C		CHEMBL1958337		Activity			CHEMBL1795186	Homo sapiens	Activity		
Active	8056045	CHEMBL1959070	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2		CHEMBL285674		Activity			CHEMBL1795186	Homo sapiens	Activity		
Not Active	8056046	CHEMBL1959070	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	CCOC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc1-2		CHEMBL52030		Activity			CHEMBL1795186	Homo sapiens	Activity		
Active	8056047	CHEMBL1959070	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2		CHEMBL655		Activity			CHEMBL1795186	Homo sapiens	Activity		
Active	8056048	CHEMBL1959070	Binding affinity to BRD3-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2		CHEMBL646		Activity			CHEMBL1795186	Homo sapiens	Activity		
	12062960	CHEMBL2156111	Binding affinity to N-terminal portion of human Brd3 containing bromodomain BD12 expressed in Escherichia coli by isothermal titration calorimetric analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	Kd	nM	19.0	CHEMBL1795186	Homo sapiens	Kd	nM	19.0
	12062968	CHEMBL2156118	Displacement of tetra-acetylated H4 peptide from human Brd3 bromodomain BD12 after 1 hr by FRET analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	IC50	nM	28.4	CHEMBL1795186	Homo sapiens	IC50	nM	28.4
	12062971	CHEMBL2156118	Displacement of tetra-acetylated H4 peptide from human Brd3 bromodomain BD12 after 1 hr by FRET analysis	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	IC50	nM	42.4	CHEMBL1795186	Homo sapiens	IC50	nM	42.4
Dose-dependent effect	12062976	CHEMBL2156118	Displacement of tetra-acetylated H4 peptide from human Brd3 bromodomain BD12 after 1 hr by FRET analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Dose-dependent effect	12062979	CHEMBL2156118	Displacement of tetra-acetylated H4 peptide from human Brd3 bromodomain BD12 after 1 hr by FRET analysis	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
	12134077	CHEMBL2183674	Binding affinity to BRD3 isoform 2 assessed as change in melting temperature at 10 uM by thermal shift assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta Tm	degrees C	5.45	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	5.45
	12134078	CHEMBL2183676	Binding affinity to BRD3 isoform 1 assessed as change in melting temperature at 10 uM by thermal shift assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta Tm	degrees C	5.24	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	5.24
	12135006	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@@H](C)c3ccccn3)c12		CHEMBL2181820	=	IC50	nM	630.96	CHEMBL1795186	Homo sapiens	pIC50		6.2
	12135007	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	IC50	nM	251.19	CHEMBL1795186	Homo sapiens	pIC50		6.6
	12135008	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@@H](C)c3ccccc3)c12		CHEMBL2017289	=	IC50	nM	630.96	CHEMBL1795186	Homo sapiens	pIC50		6.2
	12135009	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccc3)c12		CHEMBL2017288	=	IC50	nM	199.53	CHEMBL1795186	Homo sapiens	pIC50		6.7
	12135010	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(Cc3ccccn3)c12		CHEMBL2017286	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	12135011	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(Cc3ccccc3)c12		CHEMBL2017285	=	IC50	nM	251.19	CHEMBL1795186	Homo sapiens	pIC50		6.6
	12135012	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(-c3ccccc3F)c12		CHEMBL2017282	=	IC50	nM	630.96	CHEMBL1795186	Homo sapiens	pIC50		6.2
	12135013	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(-c3ccccc3C(C)(C)C)c12		CHEMBL2017283	=	IC50	nM	398.11	CHEMBL1795186	Homo sapiens	pIC50		6.4
	12135014	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(NC3CCCCC3)c(C(N)=O)cnc2cc1-c1c(C)noc1C		CHEMBL2017277	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	12135015	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(Nc3cccc4cccnc34)c(C(N)=O)cnc2cc1-c1c(C)noc1C		CHEMBL2017281	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	12135016	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(Nc3ccccc3F)ccnc2cc1-c1c(C)noc1C		CHEMBL2181819	=	IC50	nM	1584.89	CHEMBL1795186	Homo sapiens	pIC50		5.8
	12135017	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(Nc3ccccc3F)c(C(N)=O)cnc2cc1-c1c(C)noc1C		CHEMBL2017273	=	IC50	nM	316.23	CHEMBL1795186	Homo sapiens	pIC50		6.5
	12135018	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	Cc1noc(C)c1-c1ccc2c(Nc3ccccc3F)c(C(N)=O)cnc2c1		CHEMBL2017264	=	IC50	nM	3162.28	CHEMBL1795186	Homo sapiens	pIC50		5.5
	12135019	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	Cc1noc(C)c1-c1ccc2c(Nc3ccccc3F)c(C(=O)O)cnc2c1		CHEMBL2181818	=	IC50	nM	630.96	CHEMBL1795186	Homo sapiens	pIC50		6.2
	12135020	CHEMBL2187904	Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	Cc1noc(C)c1-c1ccc2c(Nc3ccccc3C(C)(C)C)c(C(=O)O)cnc2c1		CHEMBL2017269	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	12161619	CHEMBL2182551	Inhibition of His6FLAG-tagged BRD3-BD12 expressed in Escherichia coli assessed as change in melting temperature at 100 uM by thermal shift assay	B	Cc1noc(C)c1-c1ccc(OCCCN2CCOCC2)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181718	=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	12161620	CHEMBL2182551	Inhibition of His6FLAG-tagged BRD3-BD12 expressed in Escherichia coli assessed as change in melting temperature at 100 uM by thermal shift assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181721	=	Delta Tm	degrees C	2.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	2.0
	12161627	CHEMBL2182556	Binding affinity to His6-tagged BRD3 expressed in Escherichia coli by isothermal colorimetric analysis	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	89.0	CHEMBL1795186	Homo sapiens	Kd	nM	89.0
	12161628	CHEMBL2182556	Binding affinity to His6-tagged BRD3 expressed in Escherichia coli by isothermal colorimetric analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1		CHEMBL1738926	=	Kd	nM	19.0	CHEMBL1795186	Homo sapiens	Kd	nM	19.0
	12161674	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1noc(C)c1-c1ccc(OCCCN2CCOCC2)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181718	=	IC50	nM	1100.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.1
	12161675	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1noc(C)c1-c1ccc(OCCN2CCNCC2)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181717	=	IC50	nM	2200.0	CHEMBL1795186	Homo sapiens	IC50	uM	2.2
	12161676	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1noc(C)c1-c1ccc(O)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181716	=	IC50	nM	1400.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.4
	12161677	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1noc(C)c1-c1cccc(S(=O)(=O)NC2CC2)c1		CHEMBL2181715	=	IC50	nM	3000.0	CHEMBL1795186	Homo sapiens	IC50	uM	3.0
	12161678	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCNC1		CHEMBL2181714	=	IC50	nM	13000.0	CHEMBL1795186	Homo sapiens	IC50	uM	13.0
	12161679	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCNC1		CHEMBL2181713	=	IC50	nM	8400.0	CHEMBL1795186	Homo sapiens	IC50	uM	8.4
	12161680	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCNCC1		CHEMBL2181712	=	IC50	nM	21000.0	CHEMBL1795186	Homo sapiens	IC50	uM	21.0
	12161681	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCNCC1		CHEMBL2181711	=	IC50	nM	11000.0	CHEMBL1795186	Homo sapiens	IC50	uM	11.0
	12161682	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCOCC1		CHEMBL2181710	=	IC50	nM	6500.0	CHEMBL1795186	Homo sapiens	IC50	uM	6.5
	12161683	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCOCC1		CHEMBL2181709	=	IC50	nM	3200.0	CHEMBL1795186	Homo sapiens	IC50	uM	3.2
	12161684	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCNCC1		CHEMBL2181708	=	IC50	nM	11000.0	CHEMBL1795186	Homo sapiens	IC50	uM	11.0
	12161685	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCNCC1		CHEMBL2181707	=	IC50	nM	8200.0	CHEMBL1795186	Homo sapiens	IC50	uM	8.2
	12161686	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCCCC1		CHEMBL2181706	=	IC50	nM	800.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.8
	12161687	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCCC1		CHEMBL2181705	=	IC50	nM	1100.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.1
	12161688	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	CCN(C1CCCC1)S(=O)(=O)c1cc(-c2c(C)noc2C)ccc1OC		CHEMBL2181704	=	IC50	nM	700.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.7
	12161689	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N(C)C1CCCC1		CHEMBL2181703	=	IC50	nM	700.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.7
	12161690	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	CCNS(=O)(=O)c1cc(-c2c(C)noc2C)ccc1C		CHEMBL2181702	=	IC50	nM	1500.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.5
	12161691	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(N)(=O)=O		CHEMBL2181701	=	IC50	nM	8600.0	CHEMBL1795186	Homo sapiens	IC50	uM	8.6
	12161692	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC(C)(C)C		CHEMBL2181742	=	IC50	nM	1800.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.8
	12161693	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NCCCO		CHEMBL2181741	=	IC50	nM	4200.0	CHEMBL1795186	Homo sapiens	IC50	uM	4.2
	12161694	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COCCNS(=O)(=O)c1cc(-c2c(C)noc2C)ccc1C		CHEMBL2181740	=	IC50	nM	8600.0	CHEMBL1795186	Homo sapiens	IC50	uM	8.6
	12161695	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NCCCc1ccccc1		CHEMBL2181739	=	IC50	nM	3000.0	CHEMBL1795186	Homo sapiens	IC50	uM	3.0
	12161696	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NCCc1ccccc1		CHEMBL2181738	=	IC50	nM	3300.0	CHEMBL1795186	Homo sapiens	IC50	uM	3.3
	12161697	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NCc1ccccc1		CHEMBL2181737	=	IC50	nM	14000.0	CHEMBL1795186	Homo sapiens	IC50	uM	14.0
	12161698	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NCc1ccccc1		CHEMBL2181736	=	IC50	nM	3800.0	CHEMBL1795186	Homo sapiens	IC50	uM	3.8
	12161699	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(NS(=O)(=O)c2cc(-c3c(C)noc3C)ccc2OC)cc1		CHEMBL2181735	=	IC50	nM	13000.0	CHEMBL1795186	Homo sapiens	IC50	uM	13.0
	12161700	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(NS(=O)(=O)c2cc(-c3c(C)noc3C)ccc2C)cc1		CHEMBL2181734	=	IC50	nM	5900.0	CHEMBL1795186	Homo sapiens	IC50	uM	5.9
	12161701	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1cccc(NS(=O)(=O)c2cc(-c3c(C)noc3C)ccc2OC)c1		CHEMBL2181733	=	IC50	nM	4700.0	CHEMBL1795186	Homo sapiens	IC50	uM	4.7
	12161702	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1cccc(NS(=O)(=O)c2cc(-c3c(C)noc3C)ccc2C)c1		CHEMBL2181732	=	IC50	nM	1900.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.9
	12161703	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccccc1NS(=O)(=O)c1cc(-c2c(C)noc2C)ccc1OC		CHEMBL2181731	=	IC50	nM	5400.0	CHEMBL1795186	Homo sapiens	IC50	uM	5.4
	12161704	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccccc1NS(=O)(=O)c1cc(-c2c(C)noc2C)ccc1C		CHEMBL2181730	=	IC50	nM	2100.0	CHEMBL1795186	Homo sapiens	IC50	uM	2.1
	12161705	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1ccc(Cl)cc1		CHEMBL2181729	=	IC50	nM	4000.0	CHEMBL1795186	Homo sapiens	IC50	uM	4.0
	12161706	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1cccc(Cl)c1		CHEMBL2181728	=	IC50	nM	1900.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.9
	12161707	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1ccccc1Cl		CHEMBL2181727	=	IC50	nM	4800.0	CHEMBL1795186	Homo sapiens	IC50	uM	4.8
	12161708	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1ccccc1Cl		CHEMBL2181726	=	IC50	nM	2000.0	CHEMBL1795186	Homo sapiens	IC50	uM	2.0
	12161709	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1ccccc1		CHEMBL2181725	=	IC50	nM	2200.0	CHEMBL1795186	Homo sapiens	IC50	uM	2.2
	12161710	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1ccccc1		CHEMBL2181724	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.0
	12161711	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCCC1		CHEMBL2181723	=	IC50	nM	700.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.7
	12161712	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181722	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.0
	12161713	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181721	=	IC50	nM	500.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.5
	12161714	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CC1		CHEMBL2181720	=	IC50	nM	1300.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.3
	12161715	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	IC50	nM	160.0	CHEMBL1795186	Homo sapiens	IC50	nM	160.0
	12161716	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1		CHEMBL1738926	=	IC50	nM	220.0	CHEMBL1795186	Homo sapiens	IC50	nM	220.0
	12161762	CHEMBL2182563	Inhibition of His6-tagged BRD3 expressed in Escherichia coli at 200 uM after 60 mins by fluorescence anisotropy assay	B	Cc1noc(C)c1-c1ccccc1		CHEMBL1828979	=	Inhibition	%	32.0	CHEMBL1795186	Homo sapiens	INH	%	32.0
	12161766	CHEMBL2182566	Inhibition of His6-tagged BRD3 expressed in Escherichia coli after 60 mins by fluorescence anisotropy assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	IC50	nM	390.0	CHEMBL1795186	Homo sapiens	IC50	nM	390.0
	12161767	CHEMBL2182566	Inhibition of His6-tagged BRD3 expressed in Escherichia coli after 60 mins by fluorescence anisotropy assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1		CHEMBL1738926	=	IC50	nM	350.0	CHEMBL1795186	Homo sapiens	IC50	nM	350.0
	12161771	CHEMBL2182559	Inhibition of His6-tagged BRD3 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CC1		CHEMBL2181719	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.0
	12185152	CHEMBL2216379	Inhibition of BRD3	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL1795186	Homo sapiens	pIC50		5.0
	13455977	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	CCOC(=O)NC1N=C(c2ccc(Cl)cc2)c2ccccc2-n2c(C)nnc21		CHEMBL2430874	=	IC50	nM	1258.93	CHEMBL1795186	Homo sapiens	pIC50		5.9
	13455978	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	CCOC(=O)N[C@@H]1N=C(c2ccccc2)c2ccccc2-n2c(C)nnc21		CHEMBL2430873	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	13455979	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	CCOC(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2-n2c(C)nnc21		CHEMBL2430872	=	IC50	nM	100000.0	CHEMBL1795186	Homo sapiens	pIC50		4.0
	13455980	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	CCOC(=O)NC1N=C(c2ccccc2)c2ccccc2-n2c(C)nnc21		CHEMBL2430871	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	pIC50		6.0
	13455981	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)Oc1cccc(F)c1		CHEMBL2430870	=	IC50	nM	1258.93	CHEMBL1795186	Homo sapiens	pIC50		5.9
	13455982	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccc(F)cc1		CHEMBL2430869	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	pIC50		6.0
	13455983	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1ccc(C2=NC(NC(=O)OCc3ccccc3)c3nnc(C)n3-c3ccccc32)cc1		CHEMBL2430896	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	pIC50		6.0
	13455984	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	COc1ccc(C2=NC(NC(=O)OCc3ccccc3)c3nnc(C)n3-c3ccccc32)cc1		CHEMBL2430895	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	pIC50		6.0
	13455985	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	COc1cccc(C2=NC(NC(=O)OCc3ccccc3)c3nnc(C)n3-c3ccccc32)c1		CHEMBL2430894	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	pIC50		6.0
	13455986	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	COc1ccccc1C1=NC(NC(=O)OCc2ccccc2)c2nnc(C)n2-c2ccccc21		CHEMBL2430893	=	IC50	nM	5011.87	CHEMBL1795186	Homo sapiens	pIC50		5.3
	13455987	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	COc1ccc2c(c1)C(c1ccccc1)=NC(NC(=O)OCc1ccccc1)c1nnc(C)n1-2		CHEMBL2430892	=	IC50	nM	794.33	CHEMBL1795186	Homo sapiens	pIC50		6.1
	13455988	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1ccc2c(c1)-n1c(C)nnc1C(NC(=O)OCc1ccccc1)N=C2c1ccccc1		CHEMBL2430891	=	IC50	nM	1258.93	CHEMBL1795186	Homo sapiens	pIC50		5.9
	13455989	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2430890	=	IC50	nM	1584.89	CHEMBL1795186	Homo sapiens	pIC50		5.8
	13455990	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccc([N+](=O)[O-])cc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2430889	=	IC50	nM	3162.28	CHEMBL1795186	Homo sapiens	pIC50		5.5
	13455991	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2CC(=O)NCc1ccccc1		CHEMBL2430888	=	IC50	nM	1995.26	CHEMBL1795186	Homo sapiens	pIC50		5.7
	13455992	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NS(=O)(=O)Cc1ccccc1		CHEMBL2430887	=	IC50	nM	6309.57	CHEMBL1795186	Homo sapiens	pIC50		5.2
	13455993	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)NCc1ccccc1		CHEMBL2430886	=	IC50	nM	794.33	CHEMBL1795186	Homo sapiens	pIC50		6.1
	13455994	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)CCc1ccccc1		CHEMBL2430885	=	IC50	nM	3162.28	CHEMBL1795186	Homo sapiens	pIC50		5.5
	13455995	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2N		CHEMBL2430884	=	IC50	nM	12589.25	CHEMBL1795186	Homo sapiens	pIC50		4.9
	13455996	CHEMBL2433594	Binding affinity to His6-tagged BRD3 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	IC50	nM	630.96	CHEMBL1795186	Homo sapiens	pIC50		6.2
	13826158	CHEMBL3089624	Displacement of fluorescein-labeled MS574 from recombinant human BRD3 BrD2 after 1 hr by fluorescence anisotropy assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)cc(C)c1O		CHEMBL3087052	=	Ki	nM	2480.0	CHEMBL1795186	Homo sapiens	Ki	uM	2.48
	13826159	CHEMBL3089624	Displacement of fluorescein-labeled MS574 from recombinant human BRD3 BrD2 after 1 hr by fluorescence anisotropy assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)cc1O		CHEMBL3086883	=	Ki	nM	140.0	CHEMBL1795186	Homo sapiens	Ki	uM	0.14
	13826937	CHEMBL3089614	Displacement of fluorescein-labeled MS574 from recombinant human BRD3 BrD1 after 1 hr by fluorescence anisotropy assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)c(Cl)c1O		CHEMBL3086885	=	Ki	nM	240.0	CHEMBL1795186	Homo sapiens	Ki	uM	0.24
	13826938	CHEMBL3089614	Displacement of fluorescein-labeled MS574 from recombinant human BRD3 BrD1 after 1 hr by fluorescence anisotropy assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)c(C)c1O		CHEMBL3086884	=	Ki	nM	290.0	CHEMBL1795186	Homo sapiens	Ki	uM	0.29
	13826939	CHEMBL3089614	Displacement of fluorescein-labeled MS574 from recombinant human BRD3 BrD1 after 1 hr by fluorescence anisotropy assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)cc1O		CHEMBL3086883	=	Ki	nM	100.0	CHEMBL1795186	Homo sapiens	Ki	uM	0.1
	13826940	CHEMBL3089614	Displacement of fluorescein-labeled MS574 from recombinant human BRD3 BrD1 after 1 hr by fluorescence anisotropy assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)cc(C)c1O		CHEMBL3087052	=	Ki	nM	1640.0	CHEMBL1795186	Homo sapiens	Ki	uM	1.64
	13826962	CHEMBL3089624	Displacement of fluorescein-labeled MS574 from recombinant human BRD3 BrD2 after 1 hr by fluorescence anisotropy assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)c(Cl)c1O		CHEMBL3086885	=	Ki	nM	320.0	CHEMBL1795186	Homo sapiens	Ki	uM	0.32
	13826963	CHEMBL3089624	Displacement of fluorescein-labeled MS574 from recombinant human BRD3 BrD2 after 1 hr by fluorescence anisotropy assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)c(C)c1O		CHEMBL3086884	=	Ki	nM	220.0	CHEMBL1795186	Homo sapiens	Ki	uM	0.22
Active	14529944	CHEMBL3224048	Binding affinity to BRD3 in human HL60 cell nuclear extracts assessed as inhibition of protein binding to N-I-BET functionalised sepharose beads at 10 uM after 1 hr by coomassie staining-based staining-based chemoproteomic profiling	B	CC(=O)N1c2ccc(-c3ccc(NC(=O)CCCCCCC(=O)NO)cc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL3220922		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Active	14529945	CHEMBL3224048	Binding affinity to BRD3 in human HL60 cell nuclear extracts assessed as inhibition of protein binding to N-I-BET functionalised sepharose beads at 10 uM after 1 hr by coomassie staining-based staining-based chemoproteomic profiling	B	CC(=O)N1c2ccc(-c3ccccc3)cc2[C@H](NC(=O)CCCCCCC(=O)NO)C[C@@H]1C		CHEMBL3220924		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Active	14529946	CHEMBL3224048	Binding affinity to BRD3 in human HL60 cell nuclear extracts assessed as inhibition of protein binding to N-I-BET functionalised sepharose beads at 10 uM after 1 hr by coomassie staining-based staining-based chemoproteomic profiling	B	CNCc1ccc(-c2ccc3c(c2)[C@H](NC(=O)OC(C)C)C[C@H](C)N3C(C)=O)cc1		CHEMBL3220926		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Active	14529947	CHEMBL3224048	Binding affinity to BRD3 in human HL60 cell nuclear extracts assessed as inhibition of protein binding to N-I-BET functionalised sepharose beads at 10 uM after 1 hr by coomassie staining-based staining-based chemoproteomic profiling	B	CC(=O)N1c2ccc(NC(=O)CCCCCCC(=O)O)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL3220927		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
	14529953	CHEMBL3224051	Binding affinity to BRD3 in human HL60 cell nuclear extracts assessed as inhibition of protein binding to N-I-BET functionalised sepharose beads after 1 hr by coomassie staining-based chemoproteomic competition binding assay	B	CC(=O)N1c2ccc(-c3ccc(NC(=O)CCCCCCC(=O)NO)cc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL3220922	=	Kd	nM	70.0	CHEMBL1795186	Homo sapiens	Kd(app)	nM	70.0
	15086855	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccccc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353984	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	15086856	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C#N)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353985	=	IC50	nM	794.33	CHEMBL1795186	Homo sapiens	pIC50		6.1
	15086857	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COC(=O)c1ccc(-c2ccc3c(c2)[C@H](Nc2ccccc2)C[C@H](C)N3C(C)=O)cc1		CHEMBL3353986	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	pIC50		6.0
	15086858	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3352833	=	IC50	nM	398.11	CHEMBL1795186	Homo sapiens	pIC50		6.4
	15086859	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(F)(F)F)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353987	=	IC50	nM	1258.93	CHEMBL1795186	Homo sapiens	pIC50		5.9
	15086860	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COc1ccc(-c2ccc3c(c2)[C@H](Nc2ccccc2)C[C@H](C)N3C(C)=O)cc1		CHEMBL3353988	=	IC50	nM	630.96	CHEMBL1795186	Homo sapiens	pIC50		6.2
	15086861	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CO)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353989	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	15086862	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCOCC4)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353990	=	IC50	nM	630.96	CHEMBL1795186	Homo sapiens	pIC50		6.2
	15086863	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3cccc(CN4CCCCC4)c3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353991	=	IC50	nM	398.11	CHEMBL1795186	Homo sapiens	pIC50		6.4
	15086864	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCCCC4)cc3)cc2[C@H](NC=O)C[C@@H]1C		CHEMBL3353993	=	IC50	nM	6309.57	CHEMBL1795186	Homo sapiens	pIC50		5.2
	15086865	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCCCC4)cc3)cc2[C@H](N)C[C@@H]1C		CHEMBL3353994	=	IC50	nM	25118.86	CHEMBL1795186	Homo sapiens	pIC50		4.6
	15086866	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCCCC4)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353992	=	IC50	nM	316.23	CHEMBL1795186	Homo sapiens	pIC50		6.5
	15086867	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCCCC4)cc3)cc2[C@@H](Nc2ccccc2)C[C@H]1C		CHEMBL3353995	=	IC50	nM	25118.86	CHEMBL1795186	Homo sapiens	pIC50		4.6
	15086868	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COC(=O)c1ccc(-c2ccc3c(c2)[C@H](Nc2ccc(C(C)(C)C)cc2)C[C@H](C)N3C(C)=O)cc1		CHEMBL3353996	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	15086869	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(S(C)(=O)=O)cc2)C[C@@H]1C		CHEMBL3353997	=	IC50	nM	316.23	CHEMBL1795186	Homo sapiens	pIC50		6.5
	15086870	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COC(=O)c1ccc(-c2ccc3c(c2)[C@H](Nc2ccc(S(C)(=O)=O)cc2)C[C@H](C)N3C(C)=O)cc1		CHEMBL3353998	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	15086871	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(C)cc2)C[C@@H]1C		CHEMBL3353999	=	IC50	nM	316.23	CHEMBL1795186	Homo sapiens	pIC50		6.5
	15086872	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	IC50	nM	398.11	CHEMBL1795186	Homo sapiens	pIC50		6.4
	15086873	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COC(=O)c1ccc(-c2ccc3c(c2)[C@H](Nc2ccc(F)cc2)C[C@H](C)N3C(C)=O)cc1		CHEMBL3354000	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	pIC50		6.0
	15086874	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C#N)cc3)cc2[C@H](Nc2cccc(F)c2)C[C@@H]1C		CHEMBL3354001	=	IC50	nM	794.33	CHEMBL1795186	Homo sapiens	pIC50		6.1
	15086875	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COc1cccc(N[C@@H]2C[C@H](C)N(C(C)=O)c3ccc(-c4ccc(C#N)cc4)cc32)c1		CHEMBL3354002	=	IC50	nM	794.33	CHEMBL1795186	Homo sapiens	pIC50		6.1
	15086876	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COc1cccc(N[C@@H]2C[C@H](C)N(C(C)=O)c3ccc(-c4ccc(C(=O)O)cc4)cc32)c1		CHEMBL3354003	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	15086877	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COc1ccccc1N[C@@H]1C[C@H](C)N(C(C)=O)c2ccc(-c3ccc(C(=O)O)cc3)cc21		CHEMBL3354004	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	15086878	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCCCC4)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL3354005	=	IC50	nM	1258.93	CHEMBL1795186	Homo sapiens	pIC50		5.9
	15086879	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3cccc(C(=O)O)c3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL3354006	=	IC50	nM	501.19	CHEMBL1795186	Homo sapiens	pIC50		6.3
	15086880	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COC(=O)c1cccc(-c2ccc3c(c2)[C@H](Nc2ccc(Cl)cc2)C[C@H](C)N3C(C)=O)c1		CHEMBL3354007	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	pIC50		6.0
	15086881	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(N)=O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL3354008	=	IC50	nM	398.11	CHEMBL1795186	Homo sapiens	pIC50		6.4
	15086882	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccccc3C)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL3354009	=	IC50	nM	2511.89	CHEMBL1795186	Homo sapiens	pIC50		5.6
	15086883	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COc1ccc(-c2ccc3c(c2)[C@H](Nc2ccccc2)CCN3C(C)=O)cc1		CHEMBL3354010	=	IC50	nM	1584.89	CHEMBL1795186	Homo sapiens	pIC50		5.8
	15086884	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(C)cc2)C[C@@H]1C		CHEMBL3353999	=	IC50	nM	158.49	CHEMBL1795186	Homo sapiens	pIC50		6.8
	15086885	CHEMBL3382828	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD3 (1 to 475 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	IC50	nM	199.53	CHEMBL1795186	Homo sapiens	pIC50		6.7
	15091457	CHEMBL3382845	Binding affinity to His6-tagged BRD3 (1 to 475 aa) (unknown origin) by SPR method	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	Kd	nM	20.0	CHEMBL1795186	Homo sapiens	Kd	nM	20.0
	15091468	CHEMBL3383410	Inhibition of human BRD3 bromodomain 1 by BROMOscan assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	IC50	nM	0.631	CHEMBL1795186	Homo sapiens	pIC50		9.2
	15091469	CHEMBL3383411	Inhibition of human BRD3 bromodomain 2 by BROMOscan assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	IC50	nM	1.995	CHEMBL1795186	Homo sapiens	pIC50		8.7
	15091473	CHEMBL3383417	Binding affinity to full-length BRD4 short isoform (unknown origin) by BROMOscan assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	IC50	nM	0.2512	CHEMBL1795186	Homo sapiens	pIC50		9.6
	15192234	CHEMBL3414205	Inhibition of BRD3 (unknown origin) by fluorescence anisotrophy	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	IC50	nM	400.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.4
	15192235	CHEMBL3414205	Inhibition of BRD3 (unknown origin) by fluorescence anisotrophy	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	IC50	nM	250.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.25
	15613309	CHEMBL3585075	Displacement of FAM-labeled ZBA248 from BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCc1n[nH]c(CC)c1-c1nccc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL3581660	=	Ki	nM	12.9	CHEMBL1795186	Homo sapiens	Ki	nM	12.9
	15613310	CHEMBL3583406	Displacement of FAM-labeled ZBA248 from BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCc1n[nH]c(CC)c1-c1nccc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL3581660	=	Ki	nM	4.2	CHEMBL1795186	Homo sapiens	Ki	nM	4.2
	15613320	CHEMBL3585075	Displacement of FAM-labeled ZBA248 from BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ccnc(-c3c(C4CC4)n[nH]c3C)c12		CHEMBL3581661	=	Ki	nM	7.3	CHEMBL1795186	Homo sapiens	Ki	nM	7.3
	15613321	CHEMBL3583406	Displacement of FAM-labeled ZBA248 from BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ccnc(-c3c(C4CC4)n[nH]c3C)c12		CHEMBL3581661	=	Ki	nM	3.2	CHEMBL1795186	Homo sapiens	Ki	nM	3.2
	15613324	CHEMBL3583409	Binding affinity to biotinylated BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ccnc(-c3c(C4CC4)n[nH]c3C)c12		CHEMBL3581661	=	Kd	nM	17.7	CHEMBL1795186	Homo sapiens	Kd	nM	17.7
	15613325	CHEMBL3583514	Binding affinity to biotinylated BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ccnc(-c3c(C4CC4)n[nH]c3C)c12		CHEMBL3581661	=	Kd	nM	16.3	CHEMBL1795186	Homo sapiens	Kd	nM	16.3
	15613346	CHEMBL3585075	Displacement of FAM-labeled ZBA248 from BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCc1[nH]nc(-c2ccccc2)c1-c1nccc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL3581662	=	Ki	nM	10.4	CHEMBL1795186	Homo sapiens	Ki	nM	10.4
	15613347	CHEMBL3583406	Displacement of FAM-labeled ZBA248 from BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCc1[nH]nc(-c2ccccc2)c1-c1nccc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL3581662	=	Ki	nM	9.4	CHEMBL1795186	Homo sapiens	Ki	nM	9.4
	15613357	CHEMBL3585075	Displacement of FAM-labeled ZBA248 from BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Ki	nM	6.6	CHEMBL1795186	Homo sapiens	Ki	nM	6.6
	15613358	CHEMBL3583406	Displacement of FAM-labeled ZBA248 from BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Ki	nM	8.9	CHEMBL1795186	Homo sapiens	Ki	nM	8.9
	15613361	CHEMBL3583409	Binding affinity to biotinylated BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	13.6	CHEMBL1795186	Homo sapiens	Kd	nM	13.6
	15613362	CHEMBL3583514	Binding affinity to biotinylated BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	11.7	CHEMBL1795186	Homo sapiens	Kd	nM	11.7
	15613374	CHEMBL3585075	Displacement of FAM-labeled ZBA248 from BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Ki	nM	53.9	CHEMBL1795186	Homo sapiens	Ki	nM	53.9
	15613375	CHEMBL3583406	Displacement of FAM-labeled ZBA248 from BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Ki	nM	30.3	CHEMBL1795186	Homo sapiens	Ki	nM	30.3
	15613378	CHEMBL3583409	Binding affinity to biotinylated BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	60.7	CHEMBL1795186	Homo sapiens	Kd	nM	60.7
	15613379	CHEMBL3583514	Binding affinity to biotinylated BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	40.7	CHEMBL1795186	Homo sapiens	Kd	nM	40.7
	15613393	CHEMBL3585075	Displacement of FAM-labeled ZBA248 from BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Ki	nM	7.2	CHEMBL1795186	Homo sapiens	Ki	nM	7.2
	15613394	CHEMBL3583406	Displacement of FAM-labeled ZBA248 from BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Ki	nM	22.3	CHEMBL1795186	Homo sapiens	Ki	nM	22.3
	15613397	CHEMBL3583409	Binding affinity to biotinylated BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Kd	nM	29.8	CHEMBL1795186	Homo sapiens	Kd	nM	29.8
	15613398	CHEMBL3583514	Binding affinity to biotinylated BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Kd	nM	40.5	CHEMBL1795186	Homo sapiens	Kd	nM	40.5
	15613412	CHEMBL3585075	Displacement of FAM-labeled ZBA248 from BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	10.7	CHEMBL1795186	Homo sapiens	Ki	nM	10.7
	15613413	CHEMBL3583406	Displacement of FAM-labeled ZBA248 from BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	4.0	CHEMBL1795186	Homo sapiens	Ki	nM	4.0
	15627975	CHEMBL3587528	Binding affinity to 6-His-Thr BRD3 (1 to 435) BD1 (unknown origin) harboring BD2 Y348A mutant	B	Cc1cncc(-c2cnc(NC3CCNCC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3585452	=	IC50	nM	7943.28	CHEMBL1795186	Homo sapiens	pIC50		5.1
	15627976	CHEMBL3587528	Binding affinity to 6-His-Thr BRD3 (1 to 435) BD1 (unknown origin) harboring BD2 Y348A mutant	B	COc1cncc(-c2cnc(NC3CCNCC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3585455	=	IC50	nM	6309.57	CHEMBL1795186	Homo sapiens	pIC50		5.2
	15627977	CHEMBL3587529	Binding affinity to BRD3 6-His-Thr BRD3 (1 to 435) BD2 (unknown origin) harboring BD1 Y37A mutant	B	Cc1cncc(-c2cnc(NC3CCNCC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3585452	=	IC50	nM	19952.62	CHEMBL1795186	Homo sapiens	pIC50		4.7
	15627978	CHEMBL3587529	Binding affinity to BRD3 6-His-Thr BRD3 (1 to 435) BD2 (unknown origin) harboring BD1 Y37A mutant	B	COc1cncc(-c2cnc(NC3CCNCC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3585455	=	IC50	nM	19952.62	CHEMBL1795186	Homo sapiens	pIC50		4.7
	15636887	CHEMBL3591390	Binding affinity to BRD3 in human HUT78 cells incubated for 45 mins by mass spectrometry based bromosphere chemoproteomic assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCNC[C@H]3OCC3CCCCC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590389	=	Kd	nM	1995.26	CHEMBL1795186	Homo sapiens	pKd		5.7
	15636888	CHEMBL3591390	Binding affinity to BRD3 in human HUT78 cells incubated for 45 mins by mass spectrometry based bromosphere chemoproteomic assay	B	Cc1cncc(-c2ccc(N[C@@H]3CCNC[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590405	=	Kd	nM	1000.0	CHEMBL1795186	Homo sapiens	pKd		6.0
	15636889	CHEMBL3591390	Binding affinity to BRD3 in human HUT78 cells incubated for 45 mins by mass spectrometry based bromosphere chemoproteomic assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCN(C)C[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590408	<	Kd	nM	100000.0	CHEMBL1795186	Homo sapiens	pKd		4.0
	15636917	CHEMBL3591403	Binding affinity to BRD3 containing BD1 bromodomains (unknown origin) by TR-FRET assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCNC[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590383	<	IC50	nM	50118.72	CHEMBL1795186	Homo sapiens	pIC50		4.3
	15636918	CHEMBL3591403	Binding affinity to BRD3 containing BD1 bromodomains (unknown origin) by TR-FRET assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCN(C)C[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590408	<	IC50	nM	50118.72	CHEMBL1795186	Homo sapiens	pIC50		4.3
	15636927	CHEMBL3591408	Binding affinity to BRD3 containing BD2 bromodomains (unknown origin) by TR-FRET assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCNC[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590383	<	IC50	nM	50118.72	CHEMBL1795186	Homo sapiens	pIC50		4.3
	15636928	CHEMBL3591408	Binding affinity to BRD3 containing BD2 bromodomains (unknown origin) by TR-FRET assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCN(C)C[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590408	<	IC50	nM	50118.72	CHEMBL1795186	Homo sapiens	pIC50		4.3
Not Active	15728634	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cccc(NC(C)=O)c2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621252		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728635	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccc(NC(C)=O)cc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621251		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728636	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cnc(N)nc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621250		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728637	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccc(N)nc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621249		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728638	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccncc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621279		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728639	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cccnc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621278		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728640	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccsc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621277		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728641	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccsc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621276		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Active	15728642	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccnn2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621275		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728643	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cn[nH]c2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621274		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728644	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2c(C)nn(C)c2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621273		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Active	15728645	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2c(C)n[nH]c2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621272		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Active	15728646	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181721		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Active	15728647	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181722		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728677	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cc(N)ccc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621253		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728678	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccc(N)cc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621254		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728679	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cccc(N)c2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621255		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728680	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccccc2NS(C)(=O)=O)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621256		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Active	15728681	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccc(N)nc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621257		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728682	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cn(C)nn2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621259		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728683	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cc[n+]([O-])cc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621260		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Active	15728684	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccc(N)[n+]([O-])c2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621261		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728685	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1nc(-c2ccc(C)c(S(=O)(=O)NC3CCCC3)c2)no1		CHEMBL3621262		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728686	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-c2nnn(C)n2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621263		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728687	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-c2nnnn2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621264		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728688	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	CC(=O)NCc1ccc(C)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL3621265		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728689	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	CC(=O)Nc1ccc(C)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL3621266		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728690	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(NS(C)(=O)=O)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621267		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728691	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-n2cnnc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621268		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	15728692	CHEMBL3626420	Inhibition of BRD3 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-n2c(C)nnc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621233		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
	15728724	CHEMBL3624111	Inhibition of BRD3 (D1) (unknown origin) incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181722	=	IC50	nM	200.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.2
	15728725	CHEMBL3624111	Inhibition of BRD3 (D1) (unknown origin) incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181721	=	IC50	nM	250.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.25
	15728726	CHEMBL3624111	Inhibition of BRD3 (D1) (unknown origin) incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2c(C)n[nH]c2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621272	=	IC50	nM	1320.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.32
	15728727	CHEMBL3624111	Inhibition of BRD3 (D1) (unknown origin) incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccnn2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621275	=	IC50	nM	1710.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.71
	15728728	CHEMBL3624111	Inhibition of BRD3 (D1) (unknown origin) incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cnn(C)n2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621258	=	IC50	nM	10000.0	CHEMBL1795186	Homo sapiens	IC50	uM	10.0
	15728729	CHEMBL3624111	Inhibition of BRD3 (D1) (unknown origin) incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-n2cnnc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621268	>=	IC50	nM	10000.0	CHEMBL1795186	Homo sapiens	IC50	uM	10.0
	15728730	CHEMBL3624111	Inhibition of BRD3 (D1) (unknown origin) incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-n2c(C)nnc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621233	>=	IC50	nM	10000.0	CHEMBL1795186	Homo sapiens	IC50	uM	10.0
289305	16258146	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1[C@@H](c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654312	=	IC50	nM	33.0	CHEMBL1795186	Homo sapiens	IC50	nM	33.0
289286	16258165	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1F		CHEMBL3654293	=	IC50	nM	13.0	CHEMBL1795186	Homo sapiens	IC50	nM	13.0
289211	16259085	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CCC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650940	=	IC50	nM	28.0	CHEMBL1795186	Homo sapiens	IC50	nM	28.0
289280	16260094	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(C4CC4)nn3C)[C@H]2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654322	=	IC50	nM	13.0	CHEMBL1795186	Homo sapiens	IC50	nM	13.0
289150	16260771	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)c(C)c3[C@@H]2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650881	=	IC50	nM	25000.0	CHEMBL1795186	Homo sapiens	IC50	nM	25000.0
289311	16260968	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C(F)F)n3n1)C2=O		CHEMBL3654318	=	IC50	nM	16.0	CHEMBL1795186	Homo sapiens	IC50	nM	16.0
289247	16261122	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(CO)nn3C3CC3)C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3650976	=	IC50	nM	52.0	CHEMBL1795186	Homo sapiens	IC50	nM	52.0
289203	16262094	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(OC)c3nnc(C)n3c1)C2=O		CHEMBL3650932	=	IC50	nM	61.5	CHEMBL1795186	Homo sapiens	IC50	nM	61.5
289159	16263608	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3nn(C4CC4)cc3C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650889	=	IC50	nM	91.0	CHEMBL1795186	Homo sapiens	IC50	nM	91.0
289182	16263851	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(C)c4onc(C)c4c2)C3=O)c(OC)n1		CHEMBL3650911	=	IC50	nM	72.0	CHEMBL1795186	Homo sapiens	IC50	nM	72.0
289250	16264023	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4COC4)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3654265	=	IC50	nM	130.0	CHEMBL1795186	Homo sapiens	IC50	nM	130.0
289249	16264249	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(CO)nn3C3CC3)C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3654264	=	IC50	nM	80.0	CHEMBL1795186	Homo sapiens	IC50	nM	80.0
289160	16264520	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3nn(C4CC4)c(C(F)(F)F)c3C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650891	=	IC50	nM	150.0	CHEMBL1795186	Homo sapiens	IC50	nM	150.0
289287	16264840	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc2c(c1C)C(c1ccc(Cl)cc1F)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654294	=	IC50	nM	93.0	CHEMBL1795186	Homo sapiens	IC50	nM	93.0
289310	16265008	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc2c(c1C)C(c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654317	=	IC50	nM	65.0	CHEMBL1795186	Homo sapiens	IC50	nM	65.0
289181	16265851	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(C)c4onc(C)c4c2)C3=O)c(OC)n1		CHEMBL3650910	>	IC50	nM	37000.0	CHEMBL1795186	Homo sapiens	IC50	nM	37000.0
289198	16265976	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(CCO)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3onc(C)c3c1)C2=O		CHEMBL3650927	=	IC50	nM	86.0	CHEMBL1795186	Homo sapiens	IC50	nM	86.0
289171	16265977	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650901	=	IC50	nM	21.0	CHEMBL1795186	Homo sapiens	IC50	nM	21.0
289201	16266268	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650930	=	IC50	nM	96.0	CHEMBL1795186	Homo sapiens	IC50	nM	96.0
289192	16268191	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650921	=	IC50	nM	73.0	CHEMBL1795186	Homo sapiens	IC50	nM	73.0
289302	16268373	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc2c(c1C)C(c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654309	=	IC50	nM	61.0	CHEMBL1795186	Homo sapiens	IC50	nM	61.0
289227	16269725	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3n1)C2c1ccc(Cl)cc1		CHEMBL3650956	=	IC50	nM	24.0	CHEMBL1795186	Homo sapiens	IC50	nM	24.0
289186	16270190	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650915	=	IC50	nM	110.0	CHEMBL1795186	Homo sapiens	IC50	nM	110.0
289167	16271111	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(F)(F)F)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1		CHEMBL3650897	=	IC50	nM	280.0	CHEMBL1795186	Homo sapiens	IC50	nM	280.0
289145	16271324	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650877	=	IC50	nM	150.0	CHEMBL1795186	Homo sapiens	IC50	nM	150.0
289208	16272269	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650937	=	IC50	nM	28.0	CHEMBL1795186	Homo sapiens	IC50	nM	28.0
289242	16272697	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CC(=O)Nc1cc(N2C(=O)c3c(c(C)nn3C3CC3)C2c2ccc(Cl)cc2)nn2c(C)nnc12		CHEMBL3650971	>	IC50	nM	37000.0	CHEMBL1795186	Homo sapiens	IC50	nM	37000.0
289155	16274965	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3c(cnn3C3CC3)C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650887	=	IC50	nM	160.0	CHEMBL1795186	Homo sapiens	IC50	nM	160.0
289270	16275401	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CC(=O)N1CC(n2nc(C)c3c2C(=O)N(c2cc(C)c4nnc(C)n4c2)C3c2ccc(Cl)cc2)C1		CHEMBL3654283	=	IC50	nM	120.0	CHEMBL1795186	Homo sapiens	IC50	nM	120.0
289272	16275892	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCOC(=O)N1CC(n2nc(C)c3c2C(=O)N(c2cc(C)c4nnc(C)n4c2)C3c2ccc(Cl)cc2)C1		CHEMBL3654285	=	IC50	nM	77.0	CHEMBL1795186	Homo sapiens	IC50	nM	77.0
289297	16276551	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(F)cc1F		CHEMBL3654304	=	IC50	nM	40.0	CHEMBL1795186	Homo sapiens	IC50	nM	40.0
289156	16276787	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(cnn3C(C)C)C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650888	=	IC50	nM	59.0	CHEMBL1795186	Homo sapiens	IC50	nM	59.0
289162	16277158	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CC(C)n1cc2c(n1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650893	=	IC50	nM	89.0	CHEMBL1795186	Homo sapiens	IC50	nM	89.0
289229	16277189	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNc1cc(N2C(=O)c3c(c(C)nn3C3CC3)C2c2ccc(Cl)cc2)nn2c(C)nnc12		CHEMBL3650958	=	IC50	nM	120.0	CHEMBL1795186	Homo sapiens	IC50	nM	120.0
289161	16277229	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(C)C)cc3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650892	=	IC50	nM	85.0	CHEMBL1795186	Homo sapiens	IC50	nM	85.0
289130	16277485	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@H]2c1ccc(Cl)cc1		CHEMBL3650861	=	IC50	nM	27000.0	CHEMBL1795186	Homo sapiens	IC50	nM	27000.0
289285	16277727	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(C)C)c(C)c3C2c2ccc(Cl)cc2F)cn2c(C)nnc12		CHEMBL3654292	=	IC50	nM	60.0	CHEMBL1795186	Homo sapiens	IC50	nM	60.0
289210	16278165	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CC4)c(C)c3C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3650939	=	IC50	nM	31.0	CHEMBL1795186	Homo sapiens	IC50	nM	31.0
289153	16278486	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1noc2ccc(N3C(=O)c4nn(C)c(C)c4C3c3ccc(Cl)cc3)cc12		CHEMBL3650885	=	IC50	nM	920.0	CHEMBL1795186	Homo sapiens	IC50	nM	920.0
289223	16278550	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650952	=	IC50	nM	13.0	CHEMBL1795186	Homo sapiens	IC50	nM	13.0
289166	16279444	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)c4onc(C)c4c2)C3=O)c(OC)n1		CHEMBL3639497	=	IC50	nM	100.0	CHEMBL1795186	Homo sapiens	IC50	nM	100.0
289216	16280148	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)[C@@H]3c2ccc(Cl)cc2)c(OC)n1		CHEMBL3650945	=	IC50	nM	27.0	CHEMBL1795186	Homo sapiens	IC50	nM	27.0
289197	16280988	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(CCO)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650926	=	IC50	nM	57.0	CHEMBL1795186	Homo sapiens	IC50	nM	57.0
289154	16281476	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(cnn3C3CC3)C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650886	=	IC50	nM	110.0	CHEMBL1795186	Homo sapiens	IC50	nM	110.0
289165	16282106	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(C(F)(F)F)nn3C3CC3)C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650896	=	IC50	nM	100.0	CHEMBL1795186	Homo sapiens	IC50	nM	100.0
289291	16282251	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(C)C)c(C)c3C2c2ccc(F)cc2F)cn2c(C)nnc12		CHEMBL3654298	=	IC50	nM	37.0	CHEMBL1795186	Homo sapiens	IC50	nM	37.0
289135	16282388	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)cc3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650866	=	IC50	nM	150.0	CHEMBL1795186	Homo sapiens	IC50	nM	150.0
289220	16283322	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650949	=	IC50	nM	15.0	CHEMBL1795186	Homo sapiens	IC50	nM	15.0
289254	16284091	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CNC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654269	=	IC50	nM	240.0	CHEMBL1795186	Homo sapiens	IC50	nM	240.0
289200	16284394	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1ncccc1-n1nc2c(c1C)C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650929	=	IC50	nM	97.0	CHEMBL1795186	Homo sapiens	IC50	nM	97.0
289295	16287251	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654302	=	IC50	nM	90.0	CHEMBL1795186	Homo sapiens	IC50	nM	90.0
289296	16288151	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654303	=	IC50	nM	71.0	CHEMBL1795186	Homo sapiens	IC50	nM	71.0
289212	16288530	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(OC(F)(F)F)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650941	=	IC50	nM	73.0	CHEMBL1795186	Homo sapiens	IC50	nM	73.0
289146	16289710	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1ccc3nnc(C)n3c1)C2c1ccc(Cl)cc1		CHEMBL3650878	=	IC50	nM	250.0	CHEMBL1795186	Homo sapiens	IC50	nM	250.0
289233	16289979	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(C4CC4)nn3-c3ccnn3C)C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3650962	=	IC50	nM	38.0	CHEMBL1795186	Homo sapiens	IC50	nM	38.0
289265	16290079	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(=O)N(C)C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654326	=	IC50	nM	39.0	CHEMBL1795186	Homo sapiens	IC50	nM	39.0
289129	16290199	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@@H]2c1ccc(Cl)cc1		CHEMBL3650860	=	IC50	nM	67.0	CHEMBL1795186	Homo sapiens	IC50	nM	67.0
289144	16290360	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1[nH][n+](C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL4110697	=	IC50	nM	74.0	CHEMBL1795186	Homo sapiens	IC50	nM	74.0
289255	16290639	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CN(C)C4)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3654270	=	IC50	nM	120.0	CHEMBL1795186	Homo sapiens	IC50	nM	120.0
289139	16290676	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C1CC1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@H]2c1ccc(Cl)cc1		CHEMBL3650871	=	IC50	nM	27000.0	CHEMBL1795186	Homo sapiens	IC50	nM	27000.0
289180	16290725	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(-c2cnc(OC)nc2OC)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650909	=	IC50	nM	120.0	CHEMBL1795186	Homo sapiens	IC50	nM	120.0
289224	16291084	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(CCOCC(F)(F)F)c2c1C(c1ccc(Cl)cc1)N(c1cc(OC)c3nnc(C)n3c1)C2=O		CHEMBL3650953	=	IC50	nM	280.0	CHEMBL1795186	Homo sapiens	IC50	nM	280.0
289231	16292754	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc2c(c1C)C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650960	=	IC50	nM	46.0	CHEMBL1795186	Homo sapiens	IC50	nM	46.0
289288	16292780	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1n[nH]c2c1C(c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654295	=	IC50	nM	110.0	CHEMBL1795186	Homo sapiens	IC50	nM	110.0
289193	16292806	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)c(O)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650922	=	IC50	nM	200.0	CHEMBL1795186	Homo sapiens	IC50	nM	200.0
289239	16293077	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3n1)C2=O		CHEMBL3650968	=	IC50	nM	13000.0	CHEMBL1795186	Homo sapiens	IC50	nM	13000.0
289134	16294072	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc2c(n1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@H]2c1ccc(Cl)cc1		CHEMBL3650865	>	IC50	nM	37000.0	CHEMBL1795186	Homo sapiens	IC50	nM	37000.0
289263	16296663	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C(=O)N(C)C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654278	=	IC50	nM	120.0	CHEMBL1795186	Homo sapiens	IC50	nM	120.0
289189	16297689	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650918	=	IC50	nM	28.0	CHEMBL1795186	Homo sapiens	IC50	nM	28.0
289283	16298266	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C[C@H](O)C(F)(F)F)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654325	=	IC50	nM	45.0	CHEMBL1795186	Homo sapiens	IC50	nM	45.0
289177	16298620	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650906	=	IC50	nM	130.0	CHEMBL1795186	Homo sapiens	IC50	nM	130.0
289301	16300468	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1F		CHEMBL3654308	=	IC50	nM	36.0	CHEMBL1795186	Homo sapiens	IC50	nM	36.0
289261	16301001	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNC(=O)n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1		CHEMBL3654276	=	IC50	nM	190.0	CHEMBL1795186	Homo sapiens	IC50	nM	190.0
289187	16301788	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)c4nnc(C)n4c2)C3=O)c(OC)n1		CHEMBL3650916	=	IC50	nM	28.0	CHEMBL1795186	Homo sapiens	IC50	nM	28.0
289221	16301988	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C)c2c1C(c1ccc(Cl)cc1)N(c1cc(OC)c3nnc(C)n3c1)C2=O		CHEMBL3650950	=	IC50	nM	150.0	CHEMBL1795186	Homo sapiens	IC50	nM	150.0
289290	16302567	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1C(c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654297	=	IC50	nM	72.0	CHEMBL1795186	Homo sapiens	IC50	nM	72.0
289246	16303728	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COCc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650975	=	IC50	nM	53.0	CHEMBL1795186	Homo sapiens	IC50	nM	53.0
289240	16303994	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650969	=	IC50	nM	37000.0	CHEMBL1795186	Homo sapiens	IC50	nM	37000.0
289278	16304128	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COCc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654290	=	IC50	nM	42.0	CHEMBL1795186	Homo sapiens	IC50	nM	42.0
289137	16304169	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)cc3[C@H]2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650869	=	IC50	nM	66.0	CHEMBL1795186	Homo sapiens	IC50	nM	66.0
289276	16305221	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cn(C)c(=O)c3[nH]ccc13)C2=O		CHEMBL3654289	=	IC50	nM	52.0	CHEMBL1795186	Homo sapiens	IC50	nM	52.0
289176	16305960	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1		CHEMBL3650905	=	IC50	nM	61.0	CHEMBL1795186	Homo sapiens	IC50	nM	61.0
289241	16306309	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650970	=	IC50	nM	32.0	CHEMBL1795186	Homo sapiens	IC50	nM	32.0
289152	16307567	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1ccc(=O)n(C)n1)C2c1ccc(Cl)cc1		CHEMBL3650884	=	IC50	nM	890.0	CHEMBL1795186	Homo sapiens	IC50	nM	890.0
289225	16308168	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnn(C)c3n1)C2c1ccc(Cl)cc1		CHEMBL3650954	=	IC50	nM	27.0	CHEMBL1795186	Homo sapiens	IC50	nM	27.0
289294	16308455	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654301	=	IC50	nM	62.0	CHEMBL1795186	Homo sapiens	IC50	nM	62.0
289142	16308633	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CC4)c(C)c3[C@H]2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650874	=	IC50	nM	43.0	CHEMBL1795186	Homo sapiens	IC50	nM	43.0
289217	16309313	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1		CHEMBL3650946	=	IC50	nM	36.0	CHEMBL1795186	Homo sapiens	IC50	nM	36.0
289237	16310195	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650966	=	IC50	nM	5400.0	CHEMBL1795186	Homo sapiens	IC50	nM	5400.0
289264	16310392	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1c2c(nn1C(=O)N(C)C)C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3654279	=	IC50	nM	160.0	CHEMBL1795186	Homo sapiens	IC50	nM	160.0
289147	16310716	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1[nH]nc2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650879	=	IC50	nM	140.0	CHEMBL1795186	Homo sapiens	IC50	nM	140.0
289256	16311049	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CN(C)C2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654271	=	IC50	nM	440.0	CHEMBL1795186	Homo sapiens	IC50	nM	440.0
289169	16311405	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650899	=	IC50	nM	19.0	CHEMBL1795186	Homo sapiens	IC50	nM	19.0
289267	16311416	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CNC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654280	=	IC50	nM	160.0	CHEMBL1795186	Homo sapiens	IC50	nM	160.0
289262	16311762	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNC(=O)n1nc2c(c1C)C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654277	=	IC50	nM	200.0	CHEMBL1795186	Homo sapiens	IC50	nM	200.0
289257	16311764	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(=O)N(C)C)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3654272	=	IC50	nM	130.0	CHEMBL1795186	Homo sapiens	IC50	nM	130.0
289143	16312455	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CC4)c(C)c3[C@@H]2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650875	>	IC50	nM	6700.0	CHEMBL1795186	Homo sapiens	IC50	nM	6700.0
289289	16313580	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(F)cc1F		CHEMBL3654296	=	IC50	nM	87.0	CHEMBL1795186	Homo sapiens	IC50	nM	87.0
289148	16313810	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1[nH]nc2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650879	=	IC50	nM	180.0	CHEMBL1795186	Homo sapiens	IC50	nM	180.0
289271	16315452	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCOC(=O)N1CC(n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)C3c2ccc(Cl)cc2)C1		CHEMBL3654284	=	IC50	nM	76.0	CHEMBL1795186	Homo sapiens	IC50	nM	76.0
289128	16316638	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650859	=	IC50	nM	180.0	CHEMBL1795186	Homo sapiens	IC50	nM	180.0
289298	16317104	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc2c(c1C)C(c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654305	=	IC50	nM	51.0	CHEMBL1795186	Homo sapiens	IC50	nM	51.0
289292	16317109	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654299	=	IC50	nM	90.0	CHEMBL1795186	Homo sapiens	IC50	nM	90.0
289222	16317157	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C2CC2)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650951	=	IC50	nM	4400.0	CHEMBL1795186	Homo sapiens	IC50	nM	4400.0
289307	16317836	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)[C@@H]2c1ccc(F)cc1F		CHEMBL3654314	=	IC50	nM	31.0	CHEMBL1795186	Homo sapiens	IC50	nM	31.0
289309	16317838	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc2c(c1C)C(c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654316	=	IC50	nM	80.0	CHEMBL1795186	Homo sapiens	IC50	nM	80.0
289282	16317987	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(CO)nn3C3CC3)[C@H]2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654324	=	IC50	nM	13.0	CHEMBL1795186	Homo sapiens	IC50	nM	13.0
289232	16319257	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1		CHEMBL3650961	=	IC50	nM	32.0	CHEMBL1795186	Homo sapiens	IC50	nM	32.0
289184	16319917	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(C)C)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650913	=	IC50	nM	110.0	CHEMBL1795186	Homo sapiens	IC50	nM	110.0
289235	16320168	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650964	=	IC50	nM	17.0	CHEMBL1795186	Homo sapiens	IC50	nM	17.0
289204	16320355	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnn(C)c3c1)C2=O		CHEMBL3650933	=	IC50	nM	16.0	CHEMBL1795186	Homo sapiens	IC50	nM	16.0
289266	16320537	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(=O)N(C)C)c(C)c3[C@H]2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654327	=	IC50	nM	120.0	CHEMBL1795186	Homo sapiens	IC50	nM	120.0
289157	16320937	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3nn(C4CC4)cc3C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650889	=	IC50	nM	140.0	CHEMBL1795186	Homo sapiens	IC50	nM	140.0
289209	16321248	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650938	=	IC50	nM	27.0	CHEMBL1795186	Homo sapiens	IC50	nM	27.0
289228	16321340	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(N(C)C(=O)OC(C)(C)C)c3nnc(C)n3n1)C2=O		CHEMBL3650957	>	IC50	nM	37000.0	CHEMBL1795186	Homo sapiens	IC50	nM	37000.0
289205	16322557	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(CCOC)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650934	=	IC50	nM	44.0	CHEMBL1795186	Homo sapiens	IC50	nM	44.0
289163	16322814	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CC4)c(C(F)(F)F)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650894	=	IC50	nM	110.0	CHEMBL1795186	Homo sapiens	IC50	nM	110.0
289199	16323261	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1c2c(nn1CCO)C(=O)N(c1cc(C)c3onc(C)c3c1)C2c1ccc(Cl)cc1		CHEMBL3650928	=	IC50	nM	36.0	CHEMBL1795186	Homo sapiens	IC50	nM	36.0
289158	16323939	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CC(C)n1ncc2c1C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650890	=	IC50	nM	76.0	CHEMBL1795186	Homo sapiens	IC50	nM	76.0
289207	16325407	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(-c2ccnn2C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650936	=	IC50	nM	57.0	CHEMBL1795186	Homo sapiens	IC50	nM	57.0
289206	16325473	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(CCOC)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650935	=	IC50	nM	59.0	CHEMBL1795186	Homo sapiens	IC50	nM	59.0
289273	16325589	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CN(C)C2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654286	=	IC50	nM	200.0	CHEMBL1795186	Homo sapiens	IC50	nM	200.0
289132	16325665	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc2c(n1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650863	=	IC50	nM	130.0	CHEMBL1795186	Homo sapiens	IC50	nM	130.0
289244	16325814	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)[C@@H]2c1ccc(Cl)cc1		CHEMBL3650973	=	IC50	nM	37.0	CHEMBL1795186	Homo sapiens	IC50	nM	37.0
289202	16327011	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2cncn2C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650931	=	IC50	nM	97.0	CHEMBL1795186	Homo sapiens	IC50	nM	97.0
289274	16327911	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CN(C)C4)c(C)c3C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654287	=	IC50	nM	93.0	CHEMBL1795186	Homo sapiens	IC50	nM	93.0
289133	16330063	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc2c(n1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@@H]2c1ccc(Cl)cc1		CHEMBL3650864	=	IC50	nM	100.0	CHEMBL1795186	Homo sapiens	IC50	nM	100.0
289151	16330491	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1cc(F)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650883	=	IC50	nM	470.0	CHEMBL1795186	Homo sapiens	IC50	nM	470.0
289300	16330675	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1F		CHEMBL3654307	=	IC50	nM	36.0	CHEMBL1795186	Homo sapiens	IC50	nM	36.0
289277	16330962	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNc1cc(N2C(=O)c3c(c(C)nn3C3CC3)[C@H]2c2ccc(Cl)cc2)nn2c(C)nnc12		CHEMBL3654320	=	IC50	nM	24.0	CHEMBL1795186	Homo sapiens	IC50	nM	24.0
289179	16331534	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1nccc(-n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)C3c2ccc(Cl)cc2)n1		CHEMBL3650908	=	IC50	nM	480.0	CHEMBL1795186	Homo sapiens	IC50	nM	480.0
289215	16331835	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)[C@H]3c2ccc(Cl)cc2)c(OC)n1		CHEMBL3650944	=	IC50	nM	7600.0	CHEMBL1795186	Homo sapiens	IC50	nM	7600.0
289245	16332196	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(C4CC4)nn3C)C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3650974	=	IC50	nM	33.0	CHEMBL1795186	Homo sapiens	IC50	nM	33.0
289188	16332257	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1c2c(nn1C1CC1)C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650917	=	IC50	nM	40.0	CHEMBL1795186	Homo sapiens	IC50	nM	40.0
289141	16332310	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CC4)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650873	=	IC50	nM	77.0	CHEMBL1795186	Homo sapiens	IC50	nM	77.0
289168	16332925	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650898	>	IC50	nM	6700.0	CHEMBL1795186	Homo sapiens	IC50	nM	6700.0
289230	16332980	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3n1)C2=O		CHEMBL3650959	=	IC50	nM	37.0	CHEMBL1795186	Homo sapiens	IC50	nM	37.0
289252	16333147	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4COC4)c(C)c3C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654267	=	IC50	nM	130.0	CHEMBL1795186	Homo sapiens	IC50	nM	130.0
289275	16333183	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(CF)nn3C3CC3)C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654288	=	IC50	nM	50.0	CHEMBL1795186	Homo sapiens	IC50	nM	50.0
289195	16333575	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCOc1c2c(nn1C)C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650924	=	IC50	nM	100.0	CHEMBL1795186	Homo sapiens	IC50	nM	100.0
289173	16334771	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc(C)c3c2C(=O)N(c2cc(Cl)c(=O)n(C)c2)C3c2ccc(Cl)cc2)c(OC)n1		CHEMBL3650903	=	IC50	nM	120.0	CHEMBL1795186	Homo sapiens	IC50	nM	120.0
289214	16335189	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(C(F)(F)F)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650943	=	IC50	nM	120.0	CHEMBL1795186	Homo sapiens	IC50	nM	120.0
289268	16336115	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CNC4)c(C)c3C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654281	=	IC50	nM	110.0	CHEMBL1795186	Homo sapiens	IC50	nM	110.0
289218	16337197	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1ccc3nnn(C)c3n1)C2=O		CHEMBL3650947	=	IC50	nM	55.0	CHEMBL1795186	Homo sapiens	IC50	nM	55.0
289281	16337332	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1n[nH]c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654323	=	IC50	nM	23.0	CHEMBL1795186	Homo sapiens	IC50	nM	23.0
289138	16338410	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C1CC1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650870	=	IC50	nM	97.0	CHEMBL1795186	Homo sapiens	IC50	nM	97.0
289178	16338464	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C)c2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650907	=	IC50	nM	290.0	CHEMBL1795186	Homo sapiens	IC50	nM	290.0
289185	16339685	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C(C)C)C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650914	=	IC50	nM	130.0	CHEMBL1795186	Homo sapiens	IC50	nM	130.0
289299	16339886	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1n[nH]c2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654306	=	IC50	nM	75.0	CHEMBL1795186	Homo sapiens	IC50	nM	75.0
289234	16341591	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650963	>	IC50	nM	37000.0	CHEMBL1795186	Homo sapiens	IC50	nM	37000.0
289126	16341609	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1ccc(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650856	=	IC50	nM	520.0	CHEMBL1795186	Homo sapiens	IC50	nM	520.0
289248	16341965	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COCc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654263	=	IC50	nM	89.0	CHEMBL1795186	Homo sapiens	IC50	nM	89.0
289279	16342776	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COCc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(N)c3nnc(C)n3c1)C2=O		CHEMBL3654321	=	IC50	nM	20.0	CHEMBL1795186	Homo sapiens	IC50	nM	20.0
289140	16343325	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C1CC1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@@H]2c1ccc(Cl)cc1		CHEMBL3650872	=	IC50	nM	65.0	CHEMBL1795186	Homo sapiens	IC50	nM	65.0
289269	16343506	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CC(=O)N1CC(n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)C3c2ccc(Cl)cc2)C1		CHEMBL3654282	=	IC50	nM	130.0	CHEMBL1795186	Homo sapiens	IC50	nM	130.0
289196	16343522	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1c2c(nn1C)C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650925	=	IC50	nM	120.0	CHEMBL1795186	Homo sapiens	IC50	nM	120.0
289149	16343738	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650880	=	IC50	nM	160.0	CHEMBL1795186	Homo sapiens	IC50	nM	160.0
289172	16343949	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)C3c2ccc(Cl)cc2)c(OC)n1		CHEMBL3650902	=	IC50	nM	69.0	CHEMBL1795186	Homo sapiens	IC50	nM	69.0
289236	16344496	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650965	=	IC50	nM	83.0	CHEMBL1795186	Homo sapiens	IC50	nM	83.0
289312	16344510	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1[nH]nc2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654319	=	IC50	nM	170.0	CHEMBL1795186	Homo sapiens	IC50	nM	170.0
289260	16344525	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNC(=O)n1nc2c(c1C)C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654275	=	IC50	nM	140.0	CHEMBL1795186	Homo sapiens	IC50	nM	140.0
289253	16344550	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2COC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654268	=	IC50	nM	100.0	CHEMBL1795186	Homo sapiens	IC50	nM	100.0
289183	16344956	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650912	=	IC50	nM	88.0	CHEMBL1795186	Homo sapiens	IC50	nM	88.0
289306	16345296	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654313	=	IC50	nM	25.0	CHEMBL1795186	Homo sapiens	IC50	nM	25.0
289131	16345667	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3n[nH]cc3C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650862	=	IC50	nM	180.0	CHEMBL1795186	Homo sapiens	IC50	nM	180.0
289164	16346295	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3c(c(C(F)(F)F)nn3C3CC3)C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650895	=	IC50	nM	280.0	CHEMBL1795186	Homo sapiens	IC50	nM	280.0
289251	16346555	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2COC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654266	=	IC50	nM	130.0	CHEMBL1795186	Homo sapiens	IC50	nM	130.0
289136	16346794	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)cc3[C@@H]2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650868	>	IC50	nM	6700.0	CHEMBL1795186	Homo sapiens	IC50	nM	6700.0
289170	16347028	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650900	>	IC50	nM	6700.0	CHEMBL1795186	Homo sapiens	IC50	nM	6700.0
289284	16348481	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654291	=	IC50	nM	30.0	CHEMBL1795186	Homo sapiens	IC50	nM	30.0
289190	16349548	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650919	=	IC50	nM	29.0	CHEMBL1795186	Homo sapiens	IC50	nM	29.0
289213	16349976	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1cccc(C(F)(F)F)c1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650942	=	IC50	nM	800.0	CHEMBL1795186	Homo sapiens	IC50	nM	800.0
289243	16350228	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)[C@H]2c1ccc(Cl)cc1		CHEMBL3650972	=	IC50	nM	5100.0	CHEMBL1795186	Homo sapiens	IC50	nM	5100.0
289174	16350463	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2ccc4onc(C)c4c2)C3=O)c(OC)n1		CHEMBL3650904	=	IC50	nM	300.0	CHEMBL1795186	Homo sapiens	IC50	nM	300.0
289258	16350581	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(=O)N(C)C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654273	=	IC50	nM	150.0	CHEMBL1795186	Homo sapiens	IC50	nM	150.0
289308	16350644	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)[C@@H]2c1ccc(Cl)cc1F		CHEMBL3654315	=	IC50	nM	44.0	CHEMBL1795186	Homo sapiens	IC50	nM	44.0
289303	16351027	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ccccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1F		CHEMBL3654310	=	IC50	nM	42.0	CHEMBL1795186	Homo sapiens	IC50	nM	42.0
289238	16351296	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3n1)C2=O		CHEMBL3650967	<	IC50	nM	11.0	CHEMBL1795186	Homo sapiens	IC50	nM	11.0
289304	16351394	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654311	=	IC50	nM	40.0	CHEMBL1795186	Homo sapiens	IC50	nM	40.0
289226	16351427	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnn(C)c3n1)C2=O		CHEMBL3650955	=	IC50	nM	14.0	CHEMBL1795186	Homo sapiens	IC50	nM	14.0
289293	16351461	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ccccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(F)cc1F		CHEMBL3654300	=	IC50	nM	30.0	CHEMBL1795186	Homo sapiens	IC50	nM	30.0
289219	16351653	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650948	=	IC50	nM	6100.0	CHEMBL1795186	Homo sapiens	IC50	nM	6100.0
289191	16352174	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650920	=	IC50	nM	58.0	CHEMBL1795186	Homo sapiens	IC50	nM	58.0
289194	16353346	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650923	=	IC50	nM	91.0	CHEMBL1795186	Homo sapiens	IC50	nM	91.0
289127	16353582	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1[nH]nc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650858	=	IC50	nM	370.0	CHEMBL1795186	Homo sapiens	IC50	nM	370.0
289175	16355189	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1		CHEMBL3650905	=	IC50	nM	79.0	CHEMBL1795186	Homo sapiens	IC50	nM	79.0
289259	16355650	CHEMBL3707497	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNC(=O)n1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3654274	=	IC50	nM	270.0	CHEMBL1795186	Homo sapiens	IC50	nM	270.0
Active	16411583	CHEMBL3743453	Binding affinity to human BRD3 at 10 uM by differential scanning fluorimetry	B	CC(=O)c1cc(-c2cccc3nccn23)c2cc(N3CCOCC3)ccn12		CHEMBL3740819		Activity			CHEMBL1795186	Homo sapiens	Activity		
Active	16482728	CHEMBL3772990	Inhibition of Flag-tagged BRD3 (unknown origin)-biotinylated AcH4 (Lys5, 8, 12, 16) histone peptide binding expressed in CHO cells after 60 mins by TR-FRET assay	B	COC(=O)C[C@@H]1N=C(c2ccc(-c3cccc(C#N)c3)cc2)c2c(sc(C)c2C)-n2c(C)nnc21		CHEMBL3771129		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	16482732	CHEMBL3772987	Competitive inhibition of BRD3 in PMA /ionomycin activated human Jurkat cell lysate in presence of (S)-4-{3'-Cyano-4'-[3-(3-{2-[5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoylamino]-ethyldisulfanyl}-propionylamino)-propoxy]-biphenyl-4-yl}-2,3,9-trimethyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulene-6-yl]acetic acid ethyl ester/avidin-resin by pull down assay	B	COC(=O)C[C@H]1N=C(c2ccc(-c3cccc(C#N)c3)cc2)c2c(sc(C)c2C)-n2c(C)nnc21		CHEMBL3769538		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Dose-dependent effect	16482733	CHEMBL3772987	Competitive inhibition of BRD3 in PMA /ionomycin activated human Jurkat cell lysate in presence of (S)-4-{3'-Cyano-4'-[3-(3-{2-[5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoylamino]-ethyldisulfanyl}-propionylamino)-propoxy]-biphenyl-4-yl}-2,3,9-trimethyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulene-6-yl]acetic acid ethyl ester/avidin-resin by pull down assay	B	COC(=O)C[C@@H]1N=C(c2ccc(-c3cccc(C#N)c3)cc2)c2c(sc(C)c2C)-n2c(C)nnc21		CHEMBL3771129		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	16491878	CHEMBL3773113	Binding affinity to biotinylated BRD3 bromodomain-1 (unknown origin) expressed in Escherichia coli at 0.2 to 1 uM by Biolayer Interferometric analysis	B	CCCOc1ccn2c(C(C)=O)cc(-c3ccccc3S(C)(=O)=O)c2c1		CHEMBL3739699		Activity			CHEMBL1795186	Homo sapiens	Activity		
Not Active	16491879	CHEMBL3773113	Binding affinity to biotinylated BRD3 bromodomain-1 (unknown origin) expressed in Escherichia coli at 0.2 to 1 uM by Biolayer Interferometric analysis	B	CCCOc1ccn2c(C(C)=O)cc(-c3cccc(OC)c3)c2c1		CHEMBL3769590		Activity			CHEMBL1795186	Homo sapiens	Activity		
Not Active	16491880	CHEMBL3773114	Binding affinity to biotinylated BRD3 bromodomain-2 (unknown origin) expressed in Escherichia coli at 0.2 to 1 uM by Biolayer Interferometric analysis	B	CCCOc1ccn2c(C(C)=O)cc(-c3ccccc3S(C)(=O)=O)c2c1		CHEMBL3739699		Activity			CHEMBL1795186	Homo sapiens	Activity		
Not Active	16491881	CHEMBL3773114	Binding affinity to biotinylated BRD3 bromodomain-2 (unknown origin) expressed in Escherichia coli at 0.2 to 1 uM by Biolayer Interferometric analysis	B	CCCOc1ccn2c(C(C)=O)cc(-c3cccc(OC)c3)c2c1		CHEMBL3769590		Activity			CHEMBL1795186	Homo sapiens	Activity		
	16492337	CHEMBL3771486	Inhibition of BRD3 in human HUT78 cells incubated for 45 mins by chemoproteomic competition binding assay	B	CCn1cc(-c2cccc(C(F)(F)F)c2)c2sc(C(=N)NC3CCS(=O)(=O)CC3)cc2c1=O		CHEMBL3769507	<	IC50	nM	50118.72	CHEMBL1795186	Homo sapiens	pIC50		4.3
	16495916	CHEMBL3778790	Inhibition of GST-tagged human BRD3 bromodomain1 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCCCc1c(C)nc2nc(SCc3nc4c(c(=O)[nH]c(=O)n4CCCC)n3CC)nn2c1C		CHEMBL3774931	=	IC50	nM	62000.0	CHEMBL1795186	Homo sapiens	IC50	uM	62.0
	16495925	CHEMBL3778790	Inhibition of GST-tagged human BRD3 bromodomain1 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCCCn1c(=O)[nH]c(=O)c2c1ncn2CC		CHEMBL3775270	=	IC50	nM	4800.0	CHEMBL1795186	Homo sapiens	IC50	uM	4.8
	16495929	CHEMBL3778794	Inhibition of human BRD3 bromodomain2 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCCCn1c(=O)[nH]c(=O)c2c1ncn2CC		CHEMBL3775270	=	IC50	nM	5800.0	CHEMBL1795186	Homo sapiens	IC50	uM	5.8
	16495933	CHEMBL3778790	Inhibition of GST-tagged human BRD3 bromodomain1 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCn1cnc2c1c(=O)[nH]c(=O)n2Cc1ccc(Cl)cc1		CHEMBL3775058	=	IC50	nM	1800.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.8
	16495937	CHEMBL3778794	Inhibition of human BRD3 bromodomain2 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCn1cnc2c1c(=O)[nH]c(=O)n2Cc1ccc(Cl)cc1		CHEMBL3775058	=	IC50	nM	1800.0	CHEMBL1795186	Homo sapiens	IC50	uM	1.8
	16495941	CHEMBL3778790	Inhibition of GST-tagged human BRD3 bromodomain1 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCn1c(CSc2n[nH]c(N)n2)nc2c1c(=O)[nH]c(=O)n2Cc1ccc(Cl)cc1		CHEMBL3774900	=	IC50	nM	31700.0	CHEMBL1795186	Homo sapiens	IC50	uM	31.7
	16505769	CHEMBL3777024	Inhibition of recombinant human BRD3 bromodomain 1 expressed in bacterial system assessed as residual activity at 1 uM by bromoscan assay relative to control	B	CCCOc1cc(OCCCCN(C)C)cc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)c1		CHEMBL3774575	>	Activity	%	35.0	CHEMBL1795186	Homo sapiens	Activity	%	35.0
	16505770	CHEMBL3777025	Inhibition of recombinant human BRD3 bromodomain 2 expressed in bacterial system assessed as residual activity at 1 uM by bromoscan assay relative to control	B	CCCOc1cc(OCCCCN(C)C)cc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)c1		CHEMBL3774575	>	Activity	%	35.0	CHEMBL1795186	Homo sapiens	Activity	%	35.0
	16522469	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)Nc4ccccc4C(=O)O)ccc1c23		CHEMBL3780508	=	Delta Tm	degrees C	6.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	6.0
	16522470	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)Nc4ccc(F)cc4)ccc1c23		CHEMBL3780398	=	Delta Tm	degrees C	4.8	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	4.8
	16522471	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCCNS(=O)(=O)c1ccc2c3c(cccc13)C(=O)N2CC		CHEMBL3781449	=	Delta Tm	degrees C	6.5	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	6.5
	16522472	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)NCCCCNC(=O)OC(C)(C)C)ccc1c23		CHEMBL3782048	=	Delta Tm	degrees C	5.3	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	5.3
	16522473	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)NC4CCCCC4)ccc1c23		CHEMBL3781471	=	Delta Tm	degrees C	8.4	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.4
	16522474	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)NCC4CCN(C(C)=O)CC4)ccc1c23		CHEMBL3234253	=	Delta Tm	degrees C	3.2	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	3.2
	16522475	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)NCCCN4CCN(C)CC4)ccc1c23		CHEMBL3780381	=	Delta Tm	degrees C	3.9	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	3.9
	16522476	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCCCS(=O)(=O)Nc1ccc2c3c(cccc13)C(=O)N2CC		CHEMBL3780901	=	Delta Tm	degrees C	6.5	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	6.5
	16522477	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(NS(=O)(=O)C4CCCCC4)ccc1c23		CHEMBL3781254	=	Delta Tm	degrees C	7.8	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	7.8
	16522478	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(NS(=O)(=O)c4ccc(F)cc4)ccc1c23		CHEMBL3780128	=	Delta Tm	degrees C	7.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	7.0
	16522479	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(NS(=O)(=O)c4ccc(F)cc4F)ccc1c23		CHEMBL3780059	=	Delta Tm	degrees C	7.8	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	7.8
	16522480	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(NS(=O)(=O)c4cc(Cl)ccc4OC)ccc1c23		CHEMBL3779929	=	Delta Tm	degrees C	7.3	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	7.3
	16522481	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(NS(=O)(=O)c4cc(Br)ccc4OC)ccc1c23		CHEMBL3780429	=	Delta Tm	degrees C	6.5	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	6.5
	16522482	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta Tm	degrees C	11.4	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	11.4
	16522483	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Delta Tm	degrees C	8.7	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.7
	16522484	CHEMBL3782659	Binding affinity to human His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl		CHEMBL3622373	=	Delta Tm	degrees C	3.3	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	3.3
	16523323	CHEMBL3782821	Inhibition of human His-tagged BRD3 bromodomain 2 using biotin-H4K5acK8acK12acK16ac as substrate incubated for 30 mins by alphascreen assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	IC50	nM	510.0	CHEMBL1795186	Homo sapiens	IC50	nM	510.0
	16537736	CHEMBL3791462	Binding affinity to partial length human BRD3 bromodomain 1 by isothermal titration calorimetry	B	CCc1c(C(=O)Nc2cc(S(=O)(=O)N(CC)CC)ccc2O)[nH]c(C)c1C(C)=O		CHEMBL3787231	=	Kd	nM	2900.0	CHEMBL1795186	Homo sapiens	Kd	uM	2.9
Not Determined	16537737	CHEMBL3791462	Binding affinity to partial length human BRD3 bromodomain 1 by isothermal titration calorimetry	B	CCN(CC)S(=O)(=O)c1ccc(O)c(NC(=O)c2[nH]c(C)c(C(C)=O)c2C)c1		CHEMBL3786406		Kd			CHEMBL1795186	Homo sapiens	Kd		
Not Determined	16537738	CHEMBL3791462	Binding affinity to partial length human BRD3 bromodomain 1 by isothermal titration calorimetry	B	CCc1c(C(=O)Nc2cc(S(=O)(=O)N(CC)CC)ccc2O)[nH]c(C)c1C(N)=O		CHEMBL3785713		Kd			CHEMBL1795186	Homo sapiens	Kd		
	16537739	CHEMBL3791462	Binding affinity to partial length human BRD3 bromodomain 1 by isothermal titration calorimetry	B	CCc1c(C(=O)Nc2cc(S(=O)(=O)N(CC)CC)ccc2O)[nH]c(C)c1C(=O)CO		CHEMBL3786031	=	Kd	nM	4900.0	CHEMBL1795186	Homo sapiens	Kd	uM	4.9
Not Determined	16537740	CHEMBL3791462	Binding affinity to partial length human BRD3 bromodomain 1 by isothermal titration calorimetry	B	CCN(CC)S(=O)(=O)c1ccc(O)c(NC(=O)c2[nH]c(C)c(C(C)=O)c2C(C)C)c1		CHEMBL3786807		Kd			CHEMBL1795186	Homo sapiens	Kd		
	16537741	CHEMBL3791462	Binding affinity to partial length human BRD3 bromodomain 1 by isothermal titration calorimetry	B	CCc1c(C(=O)Nc2ccc(F)c(S(=O)(=O)N3CCOCC3)c2)[nH]c(C)c1C(C)=O		CHEMBL3786180	=	Kd	nM	6100.0	CHEMBL1795186	Homo sapiens	Kd	uM	6.1
	16537742	CHEMBL3791462	Binding affinity to partial length human BRD3 bromodomain 1 by isothermal titration calorimetry	B	CCc1c(C(=O)Nc2cccc(OCC(N)=O)c2)[nH]c(C)c1C(C)=O		CHEMBL3786260	=	Kd	nM	41000.0	CHEMBL1795186	Homo sapiens	Kd	uM	41.0
	16537743	CHEMBL3791462	Binding affinity to partial length human BRD3 bromodomain 1 by isothermal titration calorimetry	B	CCc1c(C(=O)N(C)Cc2cccc(C(N)=O)c2)[nH]c(C)c1C(C)=O		CHEMBL3785707	=	Kd	nM	50000.0	CHEMBL1795186	Homo sapiens	Kd	uM	50.0
Not Determined	16537744	CHEMBL3791462	Binding affinity to partial length human BRD3 bromodomain 1 by isothermal titration calorimetry	B	CCc1c(C(=O)NC)[nH]c(C)c1C(C)=O		CHEMBL3785648		Kd			CHEMBL1795186	Homo sapiens	Kd		
	16537745	CHEMBL3791463	Binding affinity to partial length human BRD3 bromodomain 2 by isothermal titration calorimetry	B	CCc1c(C(=O)Nc2cc(S(=O)(=O)N(CC)CC)ccc2O)[nH]c(C)c1C(C)=O		CHEMBL3787231	=	Kd	nM	2400.0	CHEMBL1795186	Homo sapiens	Kd	uM	2.4
Not Determined	16537746	CHEMBL3791463	Binding affinity to partial length human BRD3 bromodomain 2 by isothermal titration calorimetry	B	CCN(CC)S(=O)(=O)c1ccc(O)c(NC(=O)c2[nH]c(C)c(C(C)=O)c2C)c1		CHEMBL3786406		Kd			CHEMBL1795186	Homo sapiens	Kd		
Not Determined	16537747	CHEMBL3791463	Binding affinity to partial length human BRD3 bromodomain 2 by isothermal titration calorimetry	B	CCc1c(C(=O)Nc2cc(S(=O)(=O)N(CC)CC)ccc2O)[nH]c(C)c1C(N)=O		CHEMBL3785713		Kd			CHEMBL1795186	Homo sapiens	Kd		
	16537748	CHEMBL3791463	Binding affinity to partial length human BRD3 bromodomain 2 by isothermal titration calorimetry	B	CCc1c(C(=O)Nc2cc(S(=O)(=O)N(CC)CC)ccc2O)[nH]c(C)c1C(=O)CO		CHEMBL3786031	=	Kd	nM	11000.0	CHEMBL1795186	Homo sapiens	Kd	uM	11.0
Not Determined	16537749	CHEMBL3791463	Binding affinity to partial length human BRD3 bromodomain 2 by isothermal titration calorimetry	B	CCN(CC)S(=O)(=O)c1ccc(O)c(NC(=O)c2[nH]c(C)c(C(C)=O)c2C(C)C)c1		CHEMBL3786807		Kd			CHEMBL1795186	Homo sapiens	Kd		
	16537750	CHEMBL3791463	Binding affinity to partial length human BRD3 bromodomain 2 by isothermal titration calorimetry	B	CCc1c(C(=O)Nc2ccc(F)c(S(=O)(=O)N3CCOCC3)c2)[nH]c(C)c1C(C)=O		CHEMBL3786180	=	Kd	nM	18000.0	CHEMBL1795186	Homo sapiens	Kd	uM	18.0
	16537751	CHEMBL3791463	Binding affinity to partial length human BRD3 bromodomain 2 by isothermal titration calorimetry	B	CCc1c(C(=O)Nc2cccc(OCC(N)=O)c2)[nH]c(C)c1C(C)=O		CHEMBL3786260	=	Kd	nM	23000.0	CHEMBL1795186	Homo sapiens	Kd	uM	23.0
	16537752	CHEMBL3791463	Binding affinity to partial length human BRD3 bromodomain 2 by isothermal titration calorimetry	B	CCc1c(C(=O)N(C)Cc2cccc(C(N)=O)c2)[nH]c(C)c1C(C)=O		CHEMBL3785707	=	Kd	nM	19000.0	CHEMBL1795186	Homo sapiens	Kd	uM	19.0
Not Determined	16537753	CHEMBL3791463	Binding affinity to partial length human BRD3 bromodomain 2 by isothermal titration calorimetry	B	CCc1c(C(=O)NC)[nH]c(C)c1C(C)=O		CHEMBL3785648		Kd			CHEMBL1795186	Homo sapiens	Kd		
	16633136	CHEMBL3826488	Binding affinity to human BRD3 assessed as thermal shift difference at 10 uM by DSF analysis	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C		CHEMBL3823101	<	Delta Tm	degrees C	1.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	1.0
	16633137	CHEMBL3826488	Binding affinity to human BRD3 assessed as thermal shift difference at 10 uM by DSF analysis	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)C		CHEMBL3823478	<	Delta Tm	degrees C	1.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	1.0
Not Active	16633152	CHEMBL3825275	Activity at human BRD3 up to 100 uM by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)C		CHEMBL3823478		Activity			CHEMBL1795186	Homo sapiens	Activity		
	16844172	CHEMBL3877203	Inhibition of immobilized N-LY294002 bead binding to BRD3 (unknown origin) expressed in HEK293T cell nuclear extract incubated for 1 hr by LC-MS/MS analysis	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	13700.0	CHEMBL1795186	Homo sapiens	IC50	uM	13.7
	16844173	CHEMBL3877203	Inhibition of immobilized N-LY294002 bead binding to BRD3 (unknown origin) expressed in HEK293T cell nuclear extract incubated for 1 hr by LC-MS/MS analysis	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	IC50	nM	11500.0	CHEMBL1795186	Homo sapiens	IC50	uM	11.5
413848	17777809	CHEMBL3888743	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 μM compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6×His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(O)(C1CCOCC1)C(=O)N2		CHEMBL3963603	=	IC50	nM	140.0	CHEMBL1795186	Homo sapiens	IC50	nM	140.0
413849	17777810	CHEMBL3888743	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 μM compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6×His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(O)(C1CCCCC1=O)C(=O)N2		CHEMBL3929288	=	IC50	nM	25.0	CHEMBL1795186	Homo sapiens	IC50	nM	25.0
413850	17777811	CHEMBL3888743	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 μM compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6×His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(N)(c1ccccc1)C(=O)N2		CHEMBL3955162	=	IC50	nM	35.0	CHEMBL1795186	Homo sapiens	IC50	nM	35.0
413851	17777812	CHEMBL3888743	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 μM compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6×His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(N[C@H](C)CO)(c1ccccc1)C(=O)N2		CHEMBL3910920	=	IC50	nM	23.0	CHEMBL1795186	Homo sapiens	IC50	nM	23.0
413852	17777813	CHEMBL3888743	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 μM compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6×His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(c1ccccc1)(N1CCC[C@H](O)C1)C(=O)N2		CHEMBL3903717	=	IC50	nM	9.9	CHEMBL1795186	Homo sapiens	IC50	nM	9.9
413853	17777814	CHEMBL3888743	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 μM compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6×His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(NC[C@@H](C)O)(C1CCCCC1)C(=O)N2		CHEMBL3910409	=	IC50	nM	23.0	CHEMBL1795186	Homo sapiens	IC50	nM	23.0
413854	17777815	CHEMBL3888743	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 μM compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6×His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(c1ccccc1)(N1CCC[C@H](N)C1)C(=O)N2		CHEMBL3895413	=	IC50	nM	5.3	CHEMBL1795186	Homo sapiens	IC50	nM	5.3
413855	17777816	CHEMBL3888743	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 μM compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6×His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(O)(c1ccsc1)C(=O)N2		CHEMBL3895277	=	IC50	nM	14.0	CHEMBL1795186	Homo sapiens	IC50	nM	14.0
	18092547	CHEMBL4020257	Binding affinity to BRD3 BD1 to BD2 (P24 to A416 residues) (unknown origin)	B	CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1		CHEMBL3987016	=	Ki	nM	12.2	CHEMBL1795186	Homo sapiens	Ki	nM	12.2
	18148131	CHEMBL4032882	Binding affinity to human BRD3 bromodomain 2 (G306 to P416) expressed in bacterial cells by BromoScan assay	B	CNC(=O)c1c[nH]c2c(C(C)C)nc(N3CCCc4cc(-c5cnn(C)c5)c(C(F)F)cc43)cc12		CHEMBL4061254	=	Kd	nM	8700.0	CHEMBL1795186	Homo sapiens	Kd	nM	8700.0
	18149246	CHEMBL4033191	Inhibition of recombinant human N-terminal GST-tagged BRD3 bromodomain-1 (29 to 145 residues) expressed in Escherichia coli expression system after 120 mins by TR-FRET assay	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1O		CHEMBL4077274	>	IC50	nM	100000.0	CHEMBL1795186	Homo sapiens	IC50	uM	100.0
	18149247	CHEMBL4033191	Inhibition of recombinant human N-terminal GST-tagged BRD3 bromodomain-1 (29 to 145 residues) expressed in Escherichia coli expression system after 120 mins by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL2132936	=	IC50	nM	59.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.059
	18149248	CHEMBL4033192	Inhibition of recombinant human N-terminal GST-tagged BRD3 bromodomain-2 (306 to 417 residues) expressed in Escherichia coli expression system after 120 mins by TR-FRET assay	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1O		CHEMBL4077274	>	IC50	nM	100000.0	CHEMBL1795186	Homo sapiens	IC50	uM	100.0
	18149249	CHEMBL4033192	Inhibition of recombinant human N-terminal GST-tagged BRD3 bromodomain-2 (306 to 417 residues) expressed in Escherichia coli expression system after 120 mins by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL2132936	=	IC50	nM	39.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.039
	18173810	CHEMBL4038423	Binding affinity to BRD3 BD1-BD2 (P24 to P416 residues) (unknown origin) after 1 hr by Alexa-647-conjugated probe based TR-FRET assay	B	Cc1[nH]c(-c2cc(NS(C)(=O)=O)ccc2Oc2ccccc2)c2c1C(=O)CCC2		CHEMBL4063051	=	Ki	nM	35.0	CHEMBL1795186	Homo sapiens	Ki	nM	35.0
	18173811	CHEMBL4038423	Binding affinity to BRD3 BD1-BD2 (P24 to P416 residues) (unknown origin) after 1 hr by Alexa-647-conjugated probe based TR-FRET assay	B	Cc1[nH]c(-c2cc(S(C)(=O)=O)ccc2Oc2ccc(F)cc2F)c2c1C(=O)NCC2		CHEMBL3786012	=	Ki	nM	110.0	CHEMBL1795186	Homo sapiens	Ki	nM	110.0
	18173812	CHEMBL4038423	Binding affinity to BRD3 BD1-BD2 (P24 to P416 residues) (unknown origin) after 1 hr by Alexa-647-conjugated probe based TR-FRET assay	B	Cn1cc(-c2cc(S(C)(=O)=O)ccc2Oc2ccc(F)cc2F)c2cc[nH]c(=O)c21		CHEMBL4088466	=	Ki	nM	290.0	CHEMBL1795186	Homo sapiens	Ki	nM	290.0
	18201138	CHEMBL4043459	Inhibition of recombinant human His6-tagged BRD3 bromodomain 1 expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	4065.0	CHEMBL1795186	Homo sapiens	Kd	nM	4065.0
	18201140	CHEMBL4043461	Inhibition of recombinant human His6-tagged BRD3 bromodomain 2 expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	195.0	CHEMBL1795186	Homo sapiens	Kd	nM	195.0
	18201148	CHEMBL4043469	Inhibition of poly-His tagged BRD3 bromodomain 1 (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence anisotropy assay	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	=	Kd	nM	3700.0	CHEMBL1795186	Homo sapiens	Kd	uM	3.7
	18201149	CHEMBL4043470	Inhibition of poly-His tagged BRD3 bromodomain 2 (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence anisotropy assay	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2	Outside typical range	CHEMBL3770724	>	Kd	nM	300000.0	CHEMBL1795186	Homo sapiens	Kd	uM	300.0
	18201157	CHEMBL4043478	Inhibition of acetylated H4 binding to BRD3 (unknown origin)	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	IC50	nM	92.0	CHEMBL1795186	Homo sapiens	IC50	nM	92.0
	18220510	CHEMBL4047536	Inhibition of human partial length BRD3 BD1 (P24 to E144 residues) expressed in bacterial expression system assessed as residual activity at 500 nM relative to control by BROMOscan assay	B	Cc1nnc2c(Nc3cccc(CNC(=O)C(C)C)c3)nc3ccccc3n12		CHEMBL4083840	=	Activity	%	11.0	CHEMBL1795186	Homo sapiens	Activity	%	11.0
	18220511	CHEMBL4047537	Inhibition of human partial length BRD3 BD2 (G306 to P416 residues) expressed in bacterial expression system assessed as residual activity at 500 nM relative to control by BROMOscan assay	B	Cc1nnc2c(Nc3cccc(CNC(=O)C(C)C)c3)nc3ccccc3n12		CHEMBL4083840	=	Activity	%	30.0	CHEMBL1795186	Homo sapiens	Activity	%	30.0
	18237745	CHEMBL4051551	Inhibition of BRD3 BD1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange-dye based fluorescence thermal shift assay	B	Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C	Non standard unit for type	CHEMBL4086276	=	deltaTm	K	3.1	CHEMBL1795186	Homo sapiens	deltaTm	K	3.1
	18237746	CHEMBL4051552	Inhibition of BRD3 BD2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange-dye based fluorescence thermal shift assay	B	Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C	Non standard unit for type	CHEMBL4086276	=	deltaTm	K	1.7	CHEMBL1795186	Homo sapiens	deltaTm	K	1.7
	18294808	CHEMBL4123277	Inhibition of human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by BROMOscan assay relative to control	B	Cc1noc(C)c1-c1cc(O)cc(C(O)c2ccccc2)c1		CHEMBL2335143	=	Activity	%	0.5	CHEMBL1795186	Homo sapiens	Activity	%	0.5
	18294809	CHEMBL4123277	Inhibition of human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by BROMOscan assay relative to control	B	Cc1noc(C)c1-c1cc(O)cc(C(O)c2cccnc2)c1		CHEMBL4129171	=	Activity	%	1.5	CHEMBL1795186	Homo sapiens	Activity	%	1.5
	18306696	CHEMBL4130856	Inhibition of human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1 uM after 1 hr by qPCR method relative to control	B	Cc1ccc([C@H](C)Nc2ccc3c(c2)N(C2CC2)[C@H](C)C(=O)N3C)c(C)c1		CHEMBL4168169	=	Activity	%	0.3	CHEMBL1795186	Homo sapiens	Activity	%	0.3
	18306697	CHEMBL4130855	Inhibition of human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1 uM after 1 hr by qPCR method relative to control	B	Cc1ccc([C@H](C)Nc2ccc3c(c2)N(C2CC2)[C@H](C)C(=O)N3C)c(C)c1		CHEMBL4168169	=	Activity	%	0.1	CHEMBL1795186	Homo sapiens	Activity	%	0.1
	18373978	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL2132936	=	IC50	nM	19.1	CHEMBL1795186	Homo sapiens	IC50	nM	19.1
	18373979	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccccc1)CC2		CHEMBL4164698	=	IC50	nM	19.0	CHEMBL1795186	Homo sapiens	IC50	nM	19.0
	18373980	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(Cc1cccc(Br)c1)CC2		CHEMBL4174918	=	IC50	nM	21.0	CHEMBL1795186	Homo sapiens	IC50	nM	21.0
	18373981	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)CC2		CHEMBL4169877	=	IC50	nM	25.0	CHEMBL1795186	Homo sapiens	IC50	nM	25.0
	18373982	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(Cn3cccn3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4161952	=	IC50	nM	52.0	CHEMBL1795186	Homo sapiens	IC50	nM	52.0
	18373983	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(CO)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166455	=	IC50	nM	36.0	CHEMBL1795186	Homo sapiens	IC50	nM	36.0
	18373984	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3cc[nH]n3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4177080	=	IC50	nM	10.0	CHEMBL1795186	Homo sapiens	IC50	nM	10.0
	18373985	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3cnc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4176672	=	IC50	nM	14.0	CHEMBL1795186	Homo sapiens	IC50	nM	14.0
	18373986	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4168815	=	IC50	nM	9.0	CHEMBL1795186	Homo sapiens	IC50	nM	9.0
	18373987	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1ccc(-c2ccc3c(c2)N(c2ccc(Cl)cc2)CCn2nnc(C)c2-3)cn1		CHEMBL4173305	=	IC50	nM	10.0	CHEMBL1795186	Homo sapiens	IC50	nM	10.0
	18373988	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	COC(=O)c1ccc2c(c1)N(c1ccc(Cl)cc1)CCn1nnc(C)c1-2		CHEMBL4174764	=	IC50	nM	18.0	CHEMBL1795186	Homo sapiens	IC50	nM	18.0
	18373989	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)O)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166861	=	IC50	nM	16.0	CHEMBL1795186	Homo sapiens	IC50	nM	16.0
	18373990	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)Nc3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4169698	=	IC50	nM	14.0	CHEMBL1795186	Homo sapiens	IC50	nM	14.0
	18373991	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)N[C@@H](C)c3ccc(F)cc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4173537	=	IC50	nM	23.0	CHEMBL1795186	Homo sapiens	IC50	nM	23.0
	18373992	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)N[C@@H](C)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4162832	=	IC50	nM	12.0	CHEMBL1795186	Homo sapiens	IC50	nM	12.0
	18373993	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)N[C@H](C)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4176902	=	IC50	nM	13.0	CHEMBL1795186	Homo sapiens	IC50	nM	13.0
	18373994	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NCc3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166286	=	IC50	nM	21.0	CHEMBL1795186	Homo sapiens	IC50	nM	21.0
	18373995	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NC(c3ccccc3)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166671	=	IC50	nM	39.0	CHEMBL1795186	Homo sapiens	IC50	nM	39.0
	18373996	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NS(=O)(=O)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4174587	=	IC50	nM	21.0	CHEMBL1795186	Homo sapiens	IC50	nM	21.0
	18373997	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)C[C@@H]2C		CHEMBL4159455	=	IC50	nM	13.0	CHEMBL1795186	Homo sapiens	IC50	nM	13.0
	18373998	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)C[C@H]2C		CHEMBL4170756	=	IC50	nM	11.0	CHEMBL1795186	Homo sapiens	IC50	nM	11.0
	18373999	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)CC2CCO		CHEMBL4162818	=	IC50	nM	44.0	CHEMBL1795186	Homo sapiens	IC50	nM	44.0
	18374000	CHEMBL4144033	Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccccc1)C(=O)C2		CHEMBL4160537	>	IC50	nM	10000.0	CHEMBL1795186	Homo sapiens	IC50	uM	10.0
	18406499	CHEMBL4151016	Binding affinity to human BRD3 bromodomain 1 (P24 to E144 residues) expressed in bacterial expression system by BROMOscan assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12		CHEMBL4173488	=	Kd	nM	0.52	CHEMBL1795186	Homo sapiens	Kd	nM	0.52
	18406500	CHEMBL4151017	Binding affinity to human BRD3 bromodomain 2 (G306 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12		CHEMBL4173488	=	Kd	nM	0.49	CHEMBL1795186	Homo sapiens	Kd	nM	0.49
	18416364	CHEMBL4153122	Inhibition of BRD3 BD1 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	81.0	CHEMBL1795186	Homo sapiens	IC50	nM	81.0
	18416365	CHEMBL4153122	Inhibition of BRD3 BD1 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1cc(/N=N/c2ccc3c(c2)CCC(=O)N3)c(N)cc1O		CHEMBL4176038	=	IC50	nM	2275.0	CHEMBL1795186	Homo sapiens	IC50	nM	2275.0
	18416366	CHEMBL4153122	Inhibition of BRD3 BD1 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)NC3CCCC3)cc2)c(N)cc1O		CHEMBL4159382	=	IC50	nM	2493.0	CHEMBL1795186	Homo sapiens	IC50	nM	2493.0
	18416367	CHEMBL4153122	Inhibition of BRD3 BD1 (unknown origin) after 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	IC50	nM	3962.0	CHEMBL1795186	Homo sapiens	IC50	nM	3962.0
	18416368	CHEMBL4153123	Inhibition of BRD3 BD2 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	69.0	CHEMBL1795186	Homo sapiens	IC50	nM	69.0
	18416369	CHEMBL4153123	Inhibition of BRD3 BD2 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1cc(/N=N/c2ccc3c(c2)CCC(=O)N3)c(N)cc1O		CHEMBL4176038	=	IC50	nM	2193.0	CHEMBL1795186	Homo sapiens	IC50	nM	2193.0
	18416370	CHEMBL4153123	Inhibition of BRD3 BD2 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)NC3CCCC3)cc2)c(N)cc1O		CHEMBL4159382	=	IC50	nM	2241.0	CHEMBL1795186	Homo sapiens	IC50	nM	2241.0
	18416371	CHEMBL4153123	Inhibition of BRD3 BD2 (unknown origin) after 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	IC50	nM	203.0	CHEMBL1795186	Homo sapiens	IC50	nM	203.0
	18426577	CHEMBL4154875	Binding affinity to His6-tagged human BRD3 bromodomain-1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta Tm	degrees C	10.2	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	10.2
	18426578	CHEMBL4154875	Binding affinity to His6-tagged human BRD3 bromodomain-1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)OC(c1ccccc1)C(=O)N2		CHEMBL4163057	=	Delta Tm	degrees C	8.4	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.4
	18426579	CHEMBL4154875	Binding affinity to His6-tagged human BRD3 bromodomain-1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)OC(c1ccccc1F)C(=O)N2		CHEMBL4161994	=	Delta Tm	degrees C	7.8	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	7.8
	18426580	CHEMBL4154875	Binding affinity to His6-tagged human BRD3 bromodomain-1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC(C)C)C(=O)N2		CHEMBL4167192	=	Delta Tm	degrees C	9.6	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	9.6
	18426581	CHEMBL4154875	Binding affinity to His6-tagged human BRD3 bromodomain-1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC1CC1)C(=O)N2		CHEMBL4175060	=	Delta Tm	degrees C	8.7	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.7
	18426582	CHEMBL4154875	Binding affinity to His6-tagged human BRD3 bromodomain-1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	CCN1C(=O)[C@@H](CC2CC2)Oc2cc(-c3c(C)noc3C)ccc21		CHEMBL4168278	=	Delta Tm	degrees C	8.1	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.1
	18426583	CHEMBL4154875	Binding affinity to His6-tagged human BRD3 bromodomain-1 (P24 to E144 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC1CC1)C(=O)N2CCN1CCOCC1		CHEMBL4177288	=	Delta Tm	degrees C	7.2	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	7.2
	18426584	CHEMBL4154876	Binding affinity to His6-tagged human BRD3 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta Tm	degrees C	9.0	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	9.0
	18426585	CHEMBL4154876	Binding affinity to His6-tagged human BRD3 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)OC(c1ccccc1)C(=O)N2		CHEMBL4163057	=	Delta Tm	degrees C	9.3	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	9.3
	18426586	CHEMBL4154876	Binding affinity to His6-tagged human BRD3 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)OC(c1ccccc1F)C(=O)N2		CHEMBL4161994	=	Delta Tm	degrees C	8.4	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.4
	18426587	CHEMBL4154876	Binding affinity to His6-tagged human BRD3 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC(C)C)C(=O)N2		CHEMBL4167192	=	Delta Tm	degrees C	7.8	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	7.8
	18426588	CHEMBL4154876	Binding affinity to His6-tagged human BRD3 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC1CC1)C(=O)N2		CHEMBL4175060	=	Delta Tm	degrees C	7.5	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	7.5
	18426589	CHEMBL4154876	Binding affinity to His6-tagged human BRD3 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	CCN1C(=O)[C@@H](CC2CC2)Oc2cc(-c3c(C)noc3C)ccc21		CHEMBL4168278	=	Delta Tm	degrees C	4.8	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	4.8
	18426590	CHEMBL4154876	Binding affinity to His6-tagged human BRD3 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC1CC1)C(=O)N2CCN1CCOCC1		CHEMBL4177288	=	Delta Tm	degrees C	5.4	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	5.4
	18483682	CHEMBL4185436	Binding affinity to human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in bacterial expression system by BROMOscan assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(-c3ccnc4ccccc34)c12		CHEMBL4171228	=	Kd	nM	2.0	CHEMBL1795186	Homo sapiens	Kd	nM	2.0
	18483683	CHEMBL4185437	Binding affinity to human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(-c3ccnc4ccccc34)c12		CHEMBL4171228	=	Kd	nM	0.69	CHEMBL1795186	Homo sapiens	Kd	nM	0.69
	18483684	CHEMBL4185438	Binding affinity to human partial length BRD3 bromodomain 1/2 (P24 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(-c3ccnc4ccccc34)c12		CHEMBL4171228	=	Kd	nM	0.73	CHEMBL1795186	Homo sapiens	Kd	nM	0.73
	18486694	CHEMBL4186412	Binding affinity to human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in bacterial expression system by BROMOscan assay	B	CNC(=O)c1ccc(-c2cc3cccc(-c4nn(C5CCOCC5)c5c4CN(C(C)=O)CC5)c3cn2)cn1		CHEMBL4208820	=	Kd	nM	1100.0	CHEMBL1795186	Homo sapiens	Kd	nM	1100.0
	18486695	CHEMBL4186413	Binding affinity to human partial length BRD3 bromodomain 1/2 (P24 to P416 residues) by BROMOscan assay	B	CNC(=O)c1ccc(-c2cc3cccc(-c4nn(C5CCOCC5)c5c4CN(C(C)=O)CC5)c3cn2)cn1		CHEMBL4208820	=	Kd	nM	6100.0	CHEMBL1795186	Homo sapiens	Kd	nM	6100.0
	18486696	CHEMBL4186414	Binding affinity to human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	CNC(=O)c1ccc(-c2cc3cccc(-c4nn(C5CCOCC5)c5c4CN(C(C)=O)CC5)c3cn2)cn1		CHEMBL4208820	>	Kd	nM	10000.0	CHEMBL1795186	Homo sapiens	Kd	nM	10000.0
	18500972	CHEMBL4189341	Binding affinity to human BRD3 BD2 by ITC method	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	4000.0	CHEMBL1795186	Homo sapiens	Kd	uM	4.0
	18500973	CHEMBL4189342	Selectivity ratio of Kd for human BRD3 BD2 to Kd for human BRD3 BD1	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Selectivity ratio		20.0	CHEMBL1795186	Homo sapiens	Selectivity ratio		20.0
	18501174	CHEMBL4189290	Inhibition of BRD3 BD1 (unknown origin) after 30 mins by TR-FRET assay	B	CC(=O)N1c2ccc(-c3cnc(C(N)=O)nc3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4213809	=	IC50	nM	794.33	CHEMBL1795186	Homo sapiens	pIC50		6.1
	18501175	CHEMBL4189291	Inhibition of BRD3 BD2 (unknown origin) after 30 mins by TR-FRET assay	B	CC(=O)N1c2ccc(-c3cnc(C(N)=O)nc3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4213809	=	IC50	nM	31.62	CHEMBL1795186	Homo sapiens	pIC50		7.5
	18501192	CHEMBL4189290	Inhibition of BRD3 BD1 (unknown origin) after 30 mins by TR-FRET assay	B	CC(=O)N1c2ccc(C3=CCNCC3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4218735	=	IC50	nM	1258.93	CHEMBL1795186	Homo sapiens	pIC50		5.9
	18501193	CHEMBL4189291	Inhibition of BRD3 BD2 (unknown origin) after 30 mins by TR-FRET assay	B	CC(=O)N1c2ccc(C3=CCNCC3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4218735	=	IC50	nM	50.12	CHEMBL1795186	Homo sapiens	pIC50		7.3
	18501208	CHEMBL4189306	Binding affinity to human partial length DNA-tagged BRD3 BD1 expressed in bacterial by BROMOscan method	B	CC(=O)N1c2ccc(C3=CCNCC3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4218735	=	Kd	nM	912.01	CHEMBL1795186	Homo sapiens	pKd		6.04
	18501209	CHEMBL4189307	Binding affinity to human partial length DNA-tagged BRD3 BD2 expressed in bacterial by BROMOscan method	B	CC(=O)N1c2ccc(C3=CCNCC3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4218735	=	Kd	nM	19.5	CHEMBL1795186	Homo sapiens	pKd		7.71
	18501239	CHEMBL4189337	Selectivity ratio of Kd for human partial length DNA-tagged BRD3 BD1 to Kd for human partial length DNA-tagged BRD3 BD2	B	CC(=O)N1c2ccc(C3=CCNCC3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4218735	=	Selectivity ratio		47.0	CHEMBL1795186	Homo sapiens	Selectivity ratio		47.0
	18528508	CHEMBL4194905	Binding affinity to BRD3 bromodomain 1 to 2 (P24 to P416 amino acids) (unknown origin) using Alexa647-labeled BET-inhibitor as fluorescent probe by bromodomain TR-FRET binding assay	B	Cn1cc2c3c(c[nH]c3c1=O)CN(c1ccc(F)cc1F)c1ccc(CS(C)(=O)=O)cc1-2		CHEMBL4217457	=	Ki	nM	10.0	CHEMBL1795186	Homo sapiens	Ki	nM	10.0
	18528509	CHEMBL4194905	Binding affinity to BRD3 bromodomain 1 to 2 (P24 to P416 amino acids) (unknown origin) using Alexa647-labeled BET-inhibitor as fluorescent probe by bromodomain TR-FRET binding assay	B	Cn1cc2c3c(c[nH]c3c1=O)CN(c1ccccn1)c1ccc(CS(C)(=O)=O)cc1-2		CHEMBL4208129	=	Ki	nM	10.0	CHEMBL1795186	Homo sapiens	Ki	nM	10.0
	18528510	CHEMBL4194905	Binding affinity to BRD3 bromodomain 1 to 2 (P24 to P416 amino acids) (unknown origin) using Alexa647-labeled BET-inhibitor as fluorescent probe by bromodomain TR-FRET binding assay	B	Cn1cc2c3c(c[nH]c(=O)c31)-c1cc(CS(C)(=O)=O)ccc1N(c1ccc(F)cc1)C2		CHEMBL4215988	=	Ki	nM	17.0	CHEMBL1795186	Homo sapiens	Ki	nM	17.0
	18546718	CHEMBL4198512	Inhibition of human BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1 uM after 1 hr by BROMOScan assay relative to control	B	Cc1ccc(NC(=O)c2ccc3c(c2)N(C2CC2)C(C)C(=O)N3C)c(C)c1		CHEMBL4204052	=	Activity	%	0.0	CHEMBL1795186	Homo sapiens	Activity	%	0.0
	18546719	CHEMBL4198513	Inhibition of human BRD3 bromodomain 2 (G306 to P416 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1 uM after 1 hr by BROMOScan assay relative to control	B	Cc1ccc(NC(=O)c2ccc3c(c2)N(C2CC2)C(C)C(=O)N3C)c(C)c1		CHEMBL4204052	=	Activity	%	0.0	CHEMBL1795186	Homo sapiens	Activity	%	0.0
	18564882	CHEMBL4219279	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 2 (306 to 417residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL4228445	=	IC50	nM	1.9	CHEMBL1795186	Homo sapiens	IC50	nM	1.9
	18564883	CHEMBL4219279	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 2 (306 to 417residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ncc2c(n1)[nH]c1cc(-c3c(C)noc3C)c(OC)cc12		CHEMBL4228904	=	IC50	nM	189.0	CHEMBL1795186	Homo sapiens	IC50	nM	189.0
	18564884	CHEMBL4219279	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 2 (306 to 417residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Ki	nM	8.9	CHEMBL1795186	Homo sapiens	Ki	nM	8.9
	18564885	CHEMBL4219279	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 2 (306 to 417residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	4.0	CHEMBL1795186	Homo sapiens	Ki	nM	4.0
	18564886	CHEMBL4219279	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 2 (306 to 417residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL4228445	=	Ki	nM	0.21	CHEMBL1795186	Homo sapiens	Ki	nM	0.21
	18564887	CHEMBL4219279	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 2 (306 to 417residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ncc2c(n1)[nH]c1cc(-c3c(C)noc3C)c(OC)cc12		CHEMBL4228904	=	Ki	nM	42.4	CHEMBL1795186	Homo sapiens	Ki	nM	42.4
	18564898	CHEMBL4219279	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 2 (306 to 417residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	IC50	nM	21.0	CHEMBL1795186	Homo sapiens	IC50	nM	21.0
	18564899	CHEMBL4219279	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 2 (306 to 417residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	56.7	CHEMBL1795186	Homo sapiens	IC50	nM	56.7
	18564900	CHEMBL4219278	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 1 (24 to 144 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ncc2c(n1)[nH]c1cc(-c3c(C)noc3C)c(OC)cc12		CHEMBL4228904	=	Ki	nM	82.1	CHEMBL1795186	Homo sapiens	Ki	nM	82.1
	18564901	CHEMBL4219278	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 1 (24 to 144 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL4228445	=	Ki	nM	0.18	CHEMBL1795186	Homo sapiens	Ki	nM	0.18
	18564902	CHEMBL4219278	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 1 (24 to 144 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	10.7	CHEMBL1795186	Homo sapiens	Ki	nM	10.7
	18564903	CHEMBL4219278	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 1 (24 to 144 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Ki	nM	6.6	CHEMBL1795186	Homo sapiens	Ki	nM	6.6
	18564904	CHEMBL4219278	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 1 (24 to 144 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ncc2c(n1)[nH]c1cc(-c3c(C)noc3C)c(OC)cc12		CHEMBL4228904	=	IC50	nM	294.0	CHEMBL1795186	Homo sapiens	IC50	nM	294.0
	18564905	CHEMBL4219278	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 1 (24 to 144 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL4228445	=	IC50	nM	6.6	CHEMBL1795186	Homo sapiens	IC50	nM	6.6
	18564906	CHEMBL4219278	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 1 (24 to 144 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	IC50	nM	38.5	CHEMBL1795186	Homo sapiens	IC50	nM	38.5
	18564907	CHEMBL4219278	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD3 bromodomain 1 (24 to 144 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	39.1	CHEMBL1795186	Homo sapiens	IC50	nM	39.1
	18752404	CHEMBL4264632	Displacement of biotinylated acetylated peptide from recombinant human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21 measured after 1 hr by Bromoscan method	B	CN(C)CCN1CCN(c2nc(NCc3cccc(Cl)c3)c3cc(-c4ccc(=O)n(C)c4)ccc3n2)CC1		CHEMBL4288569	=	Kd	nM	21.0	CHEMBL1795186	Homo sapiens	Kd	nM	21.0
	18752405	CHEMBL4264633	Displacement of biotinylated acetylated peptide from recombinant human partial length BRD3 bromodomain 1/2 (P24 to P416 residues) expressed in Escherichia coli BL21 measured after 1 hr by Bromoscan method	B	CN(C)CCN1CCN(c2nc(NCc3cccc(Cl)c3)c3cc(-c4ccc(=O)n(C)c4)ccc3n2)CC1		CHEMBL4288569	=	Kd	nM	20.0	CHEMBL1795186	Homo sapiens	Kd	nM	20.0
	18752406	CHEMBL4264634	Displacement of biotinylated acetylated peptide from recombinant human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in Escherichia coli BL21 measured after 1 hr by Bromoscan method	B	CN(C)CCN1CCN(c2nc(NCc3cccc(Cl)c3)c3cc(-c4ccc(=O)n(C)c4)ccc3n2)CC1		CHEMBL4288569	=	Kd	nM	21.0	CHEMBL1795186	Homo sapiens	Kd	nM	21.0
	18871518	CHEMBL4310085	Inhibition of human 6x-His-tagged BRD3 bromodomain 1 expressed in Escherichia coli	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	59.0	CHEMBL1795186	Homo sapiens	Kd	uM	0.059
	18871519	CHEMBL4310085	Inhibition of human 6x-His-tagged BRD3 bromodomain 1 expressed in Escherichia coli	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1O		CHEMBL4077274	>	IC50	nM	100000.0	CHEMBL1795186	Homo sapiens	IC50	uM	100.0
	18871520	CHEMBL4310085	Inhibition of human 6x-His-tagged BRD3 bromodomain 1 expressed in Escherichia coli	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	4000.0	CHEMBL1795186	Homo sapiens	Kd	uM	4.0
	18871521	CHEMBL4310085	Inhibition of human 6x-His-tagged BRD3 bromodomain 1 expressed in Escherichia coli	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	=	Kd	nM	3700.0	CHEMBL1795186	Homo sapiens	Kd	uM	3.7
	18871522	CHEMBL4310085	Inhibition of human 6x-His-tagged BRD3 bromodomain 1 expressed in Escherichia coli	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)cc1O		CHEMBL3086883	=	Ki	nM	100.0	CHEMBL1795186	Homo sapiens	Ki	uM	0.1
	18871523	CHEMBL4310086	Inhibition of human 6x-His-tagged BRD3 bromodomain 2 expressed in Escherichia coli	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	82.0	CHEMBL1795186	Homo sapiens	Kd	uM	0.082
	18871524	CHEMBL4310086	Inhibition of human 6x-His-tagged BRD3 bromodomain 2 expressed in Escherichia coli	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1O		CHEMBL4077274	>	IC50	nM	100000.0	CHEMBL1795186	Homo sapiens	IC50	uM	100.0
	18871525	CHEMBL4310086	Inhibition of human 6x-His-tagged BRD3 bromodomain 2 expressed in Escherichia coli	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	190.0	CHEMBL1795186	Homo sapiens	Kd	uM	0.19
	18871526	CHEMBL4310086	Inhibition of human 6x-His-tagged BRD3 bromodomain 2 expressed in Escherichia coli	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	>	Kd	nM	75000.0	CHEMBL1795186	Homo sapiens	Kd	uM	75.0
	18871527	CHEMBL4310086	Inhibition of human 6x-His-tagged BRD3 bromodomain 2 expressed in Escherichia coli	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)cc1O		CHEMBL3086883	=	Ki	nM	140.0	CHEMBL1795186	Homo sapiens	Ki	uM	0.14
	18871573	CHEMBL4310091	Inhibition of BRD3 N-terminal bromodomain 1 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL4521096	=	IC50	nM	11200.0	CHEMBL1795186	Homo sapiens	IC50	uM	11.2
	18871574	CHEMBL4310091	Inhibition of BRD3 N-terminal bromodomain 1 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)nnn3C3CCNCC3)n2)c1		CHEMBL4475135	=	IC50	nM	51000.0	CHEMBL1795186	Homo sapiens	IC50	uM	51.0
	18871575	CHEMBL4310091	Inhibition of BRD3 N-terminal bromodomain 1 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(CO)nnn3C3CCNCC3)n2)c1	Outside typical range	CHEMBL4533090	=	IC50	nM	200000.0	CHEMBL1795186	Homo sapiens	IC50	uM	200.0
	18871576	CHEMBL4310091	Inhibition of BRD3 N-terminal bromodomain 1 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(C)nnn3C3CCNCC3)n2)c1		CHEMBL4441390	=	IC50	nM	770.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.77
	18871577	CHEMBL4310092	Inhibition of BRD3 C-terminal bromodomain 2 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL4521096	>	IC50	nM	100000.0	CHEMBL1795186	Homo sapiens	IC50	uM	100.0
	18871578	CHEMBL4310092	Inhibition of BRD3 C-terminal bromodomain 2 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)nnn3C3CCNCC3)n2)c1	Outside typical range	CHEMBL4475135	=	IC50	nM	110000.0	CHEMBL1795186	Homo sapiens	IC50	uM	110.0
	18871579	CHEMBL4310092	Inhibition of BRD3 C-terminal bromodomain 2 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(CO)nnn3C3CCNCC3)n2)c1	Outside typical range	CHEMBL4533090	=	IC50	nM	310000.0	CHEMBL1795186	Homo sapiens	IC50	uM	310.0
	18871580	CHEMBL4310092	Inhibition of BRD3 C-terminal bromodomain 2 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(C)nnn3C3CCNCC3)n2)c1		CHEMBL4441390	=	IC50	nM	2400.0	CHEMBL1795186	Homo sapiens	IC50	uM	2.4
	18881161	CHEMBL4312046	Inhibition of BRD3 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	23.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.023
	18881162	CHEMBL4312046	Inhibition of BRD3 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCNC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL4436481	=	IC50	nM	42.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.042
	18881163	CHEMBL4312046	Inhibition of BRD3 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCN)c1nnc(C)n1-2		CHEMBL4577491	=	IC50	nM	7.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.007
	18881164	CHEMBL4312046	Inhibition of BRD3 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCNC(=O)CCCCCC1(C)C(/C=C/C=C/C=C3/N(CCCS(=O)(=O)O)c4ccc(S(=O)(=O)O)cc4C3(C)C)=[N+](CCCS(=O)(=O)[O-])c3ccc(S(=O)(=O)O)cc31)c1nnc(C)n1-2		CHEMBL4580852	>	IC50	nM	20500.0	CHEMBL1795186	Homo sapiens	IC50	uM	20.5
	18881165	CHEMBL4312046	Inhibition of BRD3 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCNC(=O)CS(=O)(=O)O)c1nnc(C)n1-2		CHEMBL4576135	=	IC50	nM	78.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.078
	18881166	CHEMBL4312046	Inhibition of BRD3 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCNC(=O)C1C(C(=O)O)C(C(=O)O)C1C(=O)O)c1nnc(C)n1-2		CHEMBL4474387	=	IC50	nM	456.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.456
	18885639	CHEMBL4313222	Displacement of Alexa Fluor 647 labelled ligand from His6-tagged BRD3 BD1(1 to 435 residues)/BD2 Y348A mutant (unknown origin) after 30 mins by TR-FRET assay	B	CC1(C2CC2)NC(=O)N(CC(=O)Nc2ccc(Br)c(S(=O)(=O)N3CCCCC3)c2)C1=O		CHEMBL4583297	<	IC50	nM	50118.72	CHEMBL1795186	Homo sapiens	pIC50		4.3
	18885640	CHEMBL4313223	Displacement of Alexa Fluor 647 labelled ligand from His6-tagged BRD3 BD2(1 to 435 residues)/BD1 Y73A mutant (unknown origin) after 30 mins by TR-FRET assay	B	CC1(C2CC2)NC(=O)N(CC(=O)Nc2ccc(Br)c(S(=O)(=O)N3CCCCC3)c2)C1=O		CHEMBL4583297	=	IC50	nM	31622.78	CHEMBL1795186	Homo sapiens	pIC50		4.5
	18956443	CHEMBL4332481	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD3 bromodomain2 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Delta Tm	degrees C	5.1	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	5.1
	18956444	CHEMBL4332481	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD3 bromodomain2 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	6.9	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	6.9
	18956445	CHEMBL4332481	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD3 bromodomain2 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	Cc1ccc2ncccc2c1-c1cc(-c2c(C)noc2C)cc2nc(C3CC3)[nH]c12		CHEMBL3926851	=	Delta Tm	degrees C	10.9	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	10.9
	18956446	CHEMBL4332480	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD3 bromodomain1 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Delta Tm	degrees C	6.5	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	6.5
	18956447	CHEMBL4332480	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD3 bromodomain1 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	5.8	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	5.8
	18956448	CHEMBL4332480	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD3 bromodomain1 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	Cc1ccc2ncccc2c1-c1cc(-c2c(C)noc2C)cc2nc(C3CC3)[nH]c12		CHEMBL3926851	=	Delta Tm	degrees C	10.1	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	10.1
	18956520	CHEMBL4332520	Binding affinity to human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in bacterial expression system after 1 hr by bromoscan assay	B	Cc1ccc2ncccc2c1-c1cc(-c2c(C)noc2C)cc2nc(C3CC3)[nH]c12		CHEMBL3926851	=	Kd	nM	1.7	CHEMBL1795186	Homo sapiens	Kd	nM	1.7
	18956521	CHEMBL4332521	Binding affinity to BRD3 bromodomain 1/2 (unknown origin) after 1 hr by bromoscan assay	B	Cc1ccc2ncccc2c1-c1cc(-c2c(C)noc2C)cc2nc(C3CC3)[nH]c12		CHEMBL3926851	=	Kd	nM	0.66	CHEMBL1795186	Homo sapiens	Kd	nM	0.66
	18956522	CHEMBL4332522	Binding affinity to human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in bacterial expression system after 1 hr by bromoscan assay	B	Cc1ccc2ncccc2c1-c1cc(-c2c(C)noc2C)cc2nc(C3CC3)[nH]c12		CHEMBL3926851	=	Kd	nM	0.65	CHEMBL1795186	Homo sapiens	Kd	nM	0.65
	19007187	CHEMBL4344650	Inhibition of human recombinant His-tagged BRD3 BD1 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1OCCCCCC(=O)NO		CHEMBL4514808	>	IC50	nM	20000.0	CHEMBL1795186	Homo sapiens	IC50	uM	20.0
	19007188	CHEMBL4344650	Inhibition of human recombinant His-tagged BRD3 BD1 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	64.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.064
Not Determined	19007189	CHEMBL4344650	Inhibition of human recombinant His-tagged BRD3 BD1 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	O=C(CCCCCCC(=O)Nc1ccccc1)NO		CHEMBL98		IC50			CHEMBL1795186	Homo sapiens	IC50		
	19007190	CHEMBL4344649	Inhibition of human recombinant His-tagged BRD3 BD2 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1OCCCCCC(=O)NO		CHEMBL4514808	>	IC50	nM	20000.0	CHEMBL1795186	Homo sapiens	IC50	uM	20.0
	19007191	CHEMBL4344649	Inhibition of human recombinant His-tagged BRD3 BD2 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	39.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.039
Not Determined	19007192	CHEMBL4344649	Inhibition of human recombinant His-tagged BRD3 BD2 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	O=C(CCCCCCC(=O)Nc1ccccc1)NO		CHEMBL98		IC50			CHEMBL1795186	Homo sapiens	IC50		
	19014780	CHEMBL4346372	Inhibition of BRD3 BD1 (unknown origin) after 1 hr by TR-FRET assay	B	CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1		CHEMBL4297454	=	Ki	nM	3140.0	CHEMBL1795186	Homo sapiens	Ki	nM	3140.0
	19014781	CHEMBL4346373	Inhibition of BRD3 BD2 (unknown origin) after 1 hr by TR-FRET assay	B	CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1		CHEMBL4297454	=	Ki	nM	4.9	CHEMBL1795186	Homo sapiens	Ki	nM	4.9
Not Active	19039956	CHEMBL4351642	Binding affinity to human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in bacterial expression system at 1 uM by BROMOscan assay	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Activity			CHEMBL1795186	Homo sapiens	Activity		
Not Active	19039957	CHEMBL4351641	Binding affinity to human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in bacterial expression system at 1 uM by BROMOscan assay	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Activity			CHEMBL1795186	Homo sapiens	Activity		
	19049588	CHEMBL4354444	Binding affinity to BRD3 bromodomain 1 (unknown origin) at 20 uM by Alpha screen assay relative to control	B	COc1ccc(Cl)cc1S(=O)(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1		CHEMBL4469223	>	Activity	%	70.0	CHEMBL1795186	Homo sapiens	Activity	%	70.0
	19049589	CHEMBL4354445	Binding affinity to BRD3 bromodomain 2 (unknown origin) at 20 uM by Alpha screen assay relative to control	B	COc1ccc(Cl)cc1S(=O)(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1		CHEMBL4469223	>	Activity	%	70.0	CHEMBL1795186	Homo sapiens	Activity	%	70.0
	19057463	CHEMBL4357115	Displacement of tetra-acetylated histone H4 peptide from recombinant human His-tagged BRD3 BD2 expressed in bacterial expression system by alphascreen assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	IC50	nM	510.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.51
	19057464	CHEMBL4357116	Displacement of tetra-acetylated histone H4 peptide from recombinant human His-tagged BRD3 BD1 expressed in bacterial expression system by alphascreen assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	IC50	nM	87000.0	CHEMBL1795186	Homo sapiens	IC50	uM	87.0
	19057644	CHEMBL4357130	Displacement of tetra-acetylated histone H4 peptide (1-21) from BRD3 BD1 (unknown origin) incubated for 30 mins followed by further incubation with tetra-acetylated histone H4 peptide (1-21) for 30 mins by Alphascreen assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c3c(cc(-n4cnc(C)c4)nc13)C(=O)N2C		CHEMBL4446421	=	IC50	nM	246.3	CHEMBL1795186	Homo sapiens	IC50	nM	246.3
	19057647	CHEMBL4357133	Displacement of tetra-acetylated histone H4 peptide (1-21) from BRD3 BD2 (unknown origin) incubated for 30 mins followed by further incubation with tetra-acetylated histone H4 peptide (1-21) for 30 mins by Alphascreen assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c3c(cc(-n4cnc(C)c4)nc13)C(=O)N2C		CHEMBL4446421	=	IC50	nM	49770.0	CHEMBL1795186	Homo sapiens	IC50	nM	49770.0
	19079056	CHEMBL4363362	Binding affinity to human recombinant BRD3 BD1 (24 to 144 residues) by fluorescence polarization assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Ki	nM	68.5	CHEMBL1795186	Homo sapiens	Ki	nM	68.5
	19079057	CHEMBL4363362	Binding affinity to human recombinant BRD3 BD1 (24 to 144 residues) by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	8.7	CHEMBL1795186	Homo sapiens	Ki	nM	8.7
	19079058	CHEMBL4363362	Binding affinity to human recombinant BRD3 BD1 (24 to 144 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4471776	=	Ki	nM	188.0	CHEMBL1795186	Homo sapiens	Ki	nM	188.0
	19079059	CHEMBL4363362	Binding affinity to human recombinant BRD3 BD1 (24 to 144 residues) by fluorescence polarization assay	B	CCn1cc(-c2ccc3c(c2)C(Nc2ccc(Cl)cc2)CCc2nnc(C)n2-3)cn1		CHEMBL4438006	=	Ki	nM	99.7	CHEMBL1795186	Homo sapiens	Ki	nM	99.7
	19079060	CHEMBL4363362	Binding affinity to human recombinant BRD3 BD1 (24 to 144 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cn[nH]c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4533303	=	Ki	nM	114.0	CHEMBL1795186	Homo sapiens	Ki	nM	114.0
	19079061	CHEMBL4363362	Binding affinity to human recombinant BRD3 BD1 (24 to 144 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Ki	nM	77.9	CHEMBL1795186	Homo sapiens	Ki	nM	77.9
	19079062	CHEMBL4363363	Binding affinity to human recombinant BRD3 BD2 (306 to 417 residues) by fluorescence polarization assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Ki	nM	94.0	CHEMBL1795186	Homo sapiens	Ki	nM	94.0
	19079063	CHEMBL4363363	Binding affinity to human recombinant BRD3 BD2 (306 to 417 residues) by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	11.2	CHEMBL1795186	Homo sapiens	Ki	nM	11.2
	19079064	CHEMBL4363363	Binding affinity to human recombinant BRD3 BD2 (306 to 417 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4471776	=	Ki	nM	11.1	CHEMBL1795186	Homo sapiens	Ki	nM	11.1
	19079065	CHEMBL4363363	Binding affinity to human recombinant BRD3 BD2 (306 to 417 residues) by fluorescence polarization assay	B	CCn1cc(-c2ccc3c(c2)C(Nc2ccc(Cl)cc2)CCc2nnc(C)n2-3)cn1		CHEMBL4438006	=	Ki	nM	8.2	CHEMBL1795186	Homo sapiens	Ki	nM	8.2
	19079066	CHEMBL4363363	Binding affinity to human recombinant BRD3 BD2 (306 to 417 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cn[nH]c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4533303	=	Ki	nM	13.9	CHEMBL1795186	Homo sapiens	Ki	nM	13.9
	19079067	CHEMBL4363363	Binding affinity to human recombinant BRD3 BD2 (306 to 417 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Ki	nM	5.3	CHEMBL1795186	Homo sapiens	Ki	nM	5.3
	19079179	CHEMBL4363369	Selectivity index, ratio of Ki for human recombinant BRD3 BD1 (24 to 144 residues) to Ki for human recombinant BRD3 BD2 (306 to 417 residues)	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4471776	=	Ratio Ki		17.0	CHEMBL1795186	Homo sapiens	Ratio Ki		17.0
	19079180	CHEMBL4363369	Selectivity index, ratio of Ki for human recombinant BRD3 BD1 (24 to 144 residues) to Ki for human recombinant BRD3 BD2 (306 to 417 residues)	B	CCn1cc(-c2ccc3c(c2)C(Nc2ccc(Cl)cc2)CCc2nnc(C)n2-3)cn1		CHEMBL4438006	=	Ratio Ki		12.0	CHEMBL1795186	Homo sapiens	Ratio Ki		12.0
	19079181	CHEMBL4363369	Selectivity index, ratio of Ki for human recombinant BRD3 BD1 (24 to 144 residues) to Ki for human recombinant BRD3 BD2 (306 to 417 residues)	B	Cc1nnc2n1-c1ccc(-c3cn[nH]c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4533303	=	Ratio Ki		8.0	CHEMBL1795186	Homo sapiens	Ratio Ki		8.0
	19079182	CHEMBL4363369	Selectivity index, ratio of Ki for human recombinant BRD3 BD1 (24 to 144 residues) to Ki for human recombinant BRD3 BD2 (306 to 417 residues)	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Ratio Ki		15.0	CHEMBL1795186	Homo sapiens	Ratio Ki		15.0
	19079185	CHEMBL4363372	Binding affinity to human partial length BRD3 BD1 (P24 to E144 residues) expressed in bacterial expression system by bromoscan assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Kd	nM	12.0	CHEMBL1795186	Homo sapiens	Kd	nM	12.0
	19079186	CHEMBL4363373	Binding affinity to human partial length BRD3 BD2 (G306 to P416 residues) expressed in bacterial expression system by bromoscan assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Kd	nM	2.6	CHEMBL1795186	Homo sapiens	Kd	nM	2.6
	19079192	CHEMBL4363379	Selectivity ratio of Kd for human partial length BRD3 BD1 (P24 to E144 residues) expressed in bacterial expression system to Kd for human partial length BRD3 BD2 (G306 to P416 residues) expressed in bacterial expression system	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Selectivity ratio		5.0	CHEMBL1795186	Homo sapiens	Selectivity ratio		5.0
	19079222	CHEMBL4363405	Selectivity index, ratio of Ki for human recombinant BRD3 BD2 (306 to 417 residues) to Ki for human recombinant BRD3 BD1 (24 to 144 residues)	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ratio Ki		1.0	CHEMBL1795186	Homo sapiens	Ratio Ki		1.0
	19079225	CHEMBL4363405	Selectivity index, ratio of Ki for human recombinant BRD3 BD2 (306 to 417 residues) to Ki for human recombinant BRD3 BD1 (24 to 144 residues)	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Ratio Ki		1.0	CHEMBL1795186	Homo sapiens	Ratio Ki		1.0
	19160085	CHEMBL4382972	Binding affinity to human BRD3 BD1 (24 to 144 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1sc(C#Cc3cnn(C)c3)c(Cc3ccccc3)c1COC2		CHEMBL4555209	=	IC50	nM	16.4	CHEMBL1795186	Homo sapiens	IC50	nM	16.4
	19160086	CHEMBL4382973	Binding affinity to human BRD3 BD2 (306 to 417 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1sc(C#Cc3cnn(C)c3)c(Cc3ccccc3)c1COC2		CHEMBL4555209	=	IC50	nM	35.1	CHEMBL1795186	Homo sapiens	IC50	nM	35.1
	19160269	CHEMBL4382972	Binding affinity to human BRD3 BD1 (24 to 144 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1sc(C#Cc3cnn(C)c3)c(Cc3ccccc3)c1COC2		CHEMBL4555209	=	Ki	nM	2.5	CHEMBL1795186	Homo sapiens	Ki	nM	2.5
	19160270	CHEMBL4382973	Binding affinity to human BRD3 BD2 (306 to 417 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1sc(C#Cc3cnn(C)c3)c(Cc3ccccc3)c1COC2		CHEMBL4555209	=	Ki	nM	6.5	CHEMBL1795186	Homo sapiens	Ki	nM	6.5
	19265551	CHEMBL4405074	Binding affinity to human partial length BRD3 BD2 (G306 to P416 residues) expressed in bacterial expression system by bromoscan assay	B	CCS(=O)(=O)Cc1cnc(Oc2ccc(F)cc2F)c(-c2cc(C)c3c(=O)[nH]ccn23)c1		CHEMBL4440098	=	Kd	nM	1.0	CHEMBL1795186	Homo sapiens	Kd	nM	1.0
	19267676	CHEMBL4405933	Binding affinity to recombinant BRD3 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	3962.0	CHEMBL1795186	Homo sapiens	Kd	nM	3962.0
	19267677	CHEMBL4405933	Binding affinity to recombinant BRD3 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@@H](O)CN4CCCCC4)c(C)c3)oc2c1		CHEMBL4549898	=	Kd	nM	1906.0	CHEMBL1795186	Homo sapiens	Kd	nM	1906.0
	19267678	CHEMBL4405933	Binding affinity to recombinant BRD3 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@@H](O)CN4CCN(C)CC4)c(C)c3)oc2c1		CHEMBL4517875	=	Kd	nM	2631.0	CHEMBL1795186	Homo sapiens	Kd	nM	2631.0
	19267679	CHEMBL4405933	Binding affinity to recombinant BRD3 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@H](O)CN4CCCCC4)c(C)c3)oc2c1		CHEMBL4455209	=	Kd	nM	2395.0	CHEMBL1795186	Homo sapiens	Kd	nM	2395.0
	19267680	CHEMBL4405933	Binding affinity to recombinant BRD3 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@H](O)CN4CCN(C)CC4)c(C)c3)oc2c1		CHEMBL4557050	=	Kd	nM	3122.0	CHEMBL1795186	Homo sapiens	Kd	nM	3122.0
	19267681	CHEMBL4405933	Binding affinity to recombinant BRD3 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	81.0	CHEMBL1795186	Homo sapiens	Kd	nM	81.0
	19267682	CHEMBL4405934	Binding affinity to recombinant BRD3 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	203.0	CHEMBL1795186	Homo sapiens	Kd	nM	203.0
	19267683	CHEMBL4405934	Binding affinity to recombinant BRD3 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@@H](O)CN4CCCCC4)c(C)c3)oc2c1		CHEMBL4549898	=	Kd	nM	1719.0	CHEMBL1795186	Homo sapiens	Kd	nM	1719.0
	19267684	CHEMBL4405934	Binding affinity to recombinant BRD3 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@@H](O)CN4CCN(C)CC4)c(C)c3)oc2c1		CHEMBL4517875	=	Kd	nM	1962.0	CHEMBL1795186	Homo sapiens	Kd	nM	1962.0
	19267685	CHEMBL4405934	Binding affinity to recombinant BRD3 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@H](O)CN4CCCCC4)c(C)c3)oc2c1		CHEMBL4455209	=	Kd	nM	2081.0	CHEMBL1795186	Homo sapiens	Kd	nM	2081.0
	19267686	CHEMBL4405934	Binding affinity to recombinant BRD3 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@H](O)CN4CCN(C)CC4)c(C)c3)oc2c1		CHEMBL4557050	=	Kd	nM	2495.0	CHEMBL1795186	Homo sapiens	Kd	nM	2495.0
	19267687	CHEMBL4405934	Binding affinity to recombinant BRD3 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	69.0	CHEMBL1795186	Homo sapiens	Kd	nM	69.0
	19307846	CHEMBL4415496	Binding affinity to human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21 cells assessed as residual binding level at 1 uM measured after 1 hr by quantitative PCR based BROMOscan assay relative to control	B	Cc1ccc(-n2nc(C(=O)N3C[C@H](C)N[C@H](C)C3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4451357	<=	Activity	%	5.0	CHEMBL1795186	Homo sapiens	Activity	%	5.0
	19307847	CHEMBL4415497	Binding affinity to human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in Escherichia coli BL21 cells assessed as residual binding level at 1 uM measured after 1 hr by quantitative PCR based BROMOscan assay relative to control	B	Cc1ccc(-n2nc(C(=O)N3C[C@H](C)N[C@H](C)C3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4451357	<=	Activity	%	5.0	CHEMBL1795186	Homo sapiens	Activity	%	5.0
	19445990	CHEMBL4432583	Inhibition of human BRD3 bromodomain 1 expressed in bacterial expression system	B	COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4)CC3)nn12		CHEMBL4078100	=	Ki	nM	63.1	CHEMBL1795186	Homo sapiens	pKi		7.2
	19445996	CHEMBL4432589	Inhibition of human BRD3 bromodomain 2 expressed in bacterial expression system	B	COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4)CC3)nn12		CHEMBL4078100	=	Ki	nM	398.11	CHEMBL1795186	Homo sapiens	pKi		6.4
	20638646	CHEMBL4612482	Binding affinity to human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in bacterial expression system by BROMOscan assay	B	CCS(=O)(=O)Nc1cc(-c2cn(C)c3c(=O)[nH]ccc23)cc2c1ccn2C(C)(c1ccccn1)c1ccccn1		CHEMBL4648912	<	Kd	nM	1.0	CHEMBL1795186	Homo sapiens	Kd	nM	1.0
	20638647	CHEMBL4612483	Binding affinity to human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	CCS(=O)(=O)Nc1cc(-c2cn(C)c3c(=O)[nH]ccc23)cc2c1ccn2C(C)(c1ccccn1)c1ccccn1		CHEMBL4648912	<	Kd	nM	1.0	CHEMBL1795186	Homo sapiens	Kd	nM	1.0
	20638648	CHEMBL4612484	Binding affinity to human partial length BRD3 bromodomain 1 and 2 (P24 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	CCS(=O)(=O)Nc1cc(-c2cn(C)c3c(=O)[nH]ccc23)cc2c1ccn2C(C)(c1ccccn1)c1ccccn1		CHEMBL4648912	<	Kd	nM	1.0	CHEMBL1795186	Homo sapiens	Kd	nM	1.0
Not Active	20679743	CHEMBL4622542	Inhibition of human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in bacterial expression system by BROMOscan assay	B	CNC(=O)c1cc(C(=O)N[C@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637298		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	20679744	CHEMBL4622543	Inhibition of BRD3 bromodomain 1/2 (unknown origin) by BROMOscan assay	B	CNC(=O)c1cc(C(=O)N[C@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637298		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
Not Active	20679745	CHEMBL4622544	Inhibition of human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	CNC(=O)c1cc(C(=O)N[C@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637298		Inhibition	%		CHEMBL1795186	Homo sapiens	INH		
	20692802	CHEMBL4625975	Binding affinity to 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1ccc(=O)n(Cc2cc(Br)ccc2F)c1		CHEMBL4637442	<	IC50	nM	50118.72	CHEMBL1795186	Homo sapiens	pIC50		4.3
	20692803	CHEMBL4625975	Binding affinity to 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1ccc(=O)n(Cc2ccccc2)c1		CHEMBL4639878	=	IC50	nM	15848.93	CHEMBL1795186	Homo sapiens	pIC50		4.8
	20692804	CHEMBL4625975	Binding affinity to 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cccn(Cc2ccccc2)c1=O		CHEMBL4633353	=	IC50	nM	12589.25	CHEMBL1795186	Homo sapiens	pIC50		4.9
	20692805	CHEMBL4625975	Binding affinity to 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134	=	IC50	nM	25118.86	CHEMBL1795186	Homo sapiens	pIC50		4.6
	20692806	CHEMBL4625975	Binding affinity to 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2cccc3[nH]ccc23)c1=O		CHEMBL4648431	=	IC50	nM	19952.62	CHEMBL1795186	Homo sapiens	pIC50		4.7
	20696168	CHEMBL4626981	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD3 BD1 (1 to 435 residues)/BD2 Y348A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128	=	IC50	nM	39.81	CHEMBL1795186	Homo sapiens	pIC50		7.4
	20696225	CHEMBL4626977	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD3 BD2 (1 to 435 residues)/BD1 Y73A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128	=	IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	pIC50		6.0
	20696249	CHEMBL4626981	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD3 BD1 (1 to 435 residues)/BD2 Y348A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	IC50	nM	31.62	CHEMBL1795186	Homo sapiens	pIC50		7.5
	20696253	CHEMBL4626977	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD3 BD2 (1 to 435 residues)/BD1 Y73A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	IC50	nM	79.43	CHEMBL1795186	Homo sapiens	pIC50		7.1
	20696266	CHEMBL4626981	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD3 BD1 (1 to 435 residues)/BD2 Y348A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4635329	=	IC50	nM	10.0	CHEMBL1795186	Homo sapiens	pIC50		8.0
	20696270	CHEMBL4626977	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD3 BD2 (1 to 435 residues)/BD1 Y73A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4635329	=	IC50	nM	15.85	CHEMBL1795186	Homo sapiens	pIC50		7.8
	20696278	CHEMBL4626990	Binding affinity to BRD3 BD2 (unknown origin) by isothermal titration calorimetric method	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2	Outside typical range	CHEMBL3770724	>	Kd	nM	300000.0	CHEMBL1795186	Homo sapiens	Kd	uM	300.0
	20696281	CHEMBL4626987	Binding affinity to BRD3 BD1 (unknown origin) by isothermal titration calorimetric method	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	=	Kd	nM	3300.0	CHEMBL1795186	Homo sapiens	Kd	uM	3.3
	20696289	CHEMBL4626985	Binding affinity to BRD3 BD1 (unknown origin) by fluorescence anisotropy competition binding assay	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	=	Ki	nM	17200.0	CHEMBL1795186	Homo sapiens	Ki	uM	17.2
	22069314	CHEMBL4650072	Thermal Shift Assay. Domain start/stop: P24-E144	B	CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OCC2CCCN(C)C2)C1		CHEMBL3906203	=	Delta TM	C	1.35	CHEMBL1795186	Homo sapiens	Delta TM	C	1.35
	22069315	CHEMBL4650072	Thermal Shift Assay. Domain start/stop: P24-E144	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta TM	C	3.99	CHEMBL1795186	Homo sapiens	Delta TM	C	3.99
	22069316	CHEMBL4650072	Thermal Shift Assay. Domain start/stop: P24-E144	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta TM	C	7.81	CHEMBL1795186	Homo sapiens	Delta TM	C	7.81
	22069317	CHEMBL4650075	Thermal Shift Assay. Domain start/stop: G306-P416	B	CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OCC2CCCN(C)C2)C1		CHEMBL3906203	=	Delta TM	C	1.01	CHEMBL1795186	Homo sapiens	Delta TM	C	1.01
	22069318	CHEMBL4650075	Thermal Shift Assay. Domain start/stop: G306-P416	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta TM	C	4.59	CHEMBL1795186	Homo sapiens	Delta TM	C	4.59
	22069319	CHEMBL4650075	Thermal Shift Assay. Domain start/stop: G306-P416	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta TM	C	7.6	CHEMBL1795186	Homo sapiens	Delta TM	C	7.6
	22069320	CHEMBL4650073	Thermal Shift Assay. Domain start/stop: P24-E144	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Delta TM	C	6.32	CHEMBL1795186	Homo sapiens	Delta TM	C	6.32
	22069321	CHEMBL4650073	Thermal Shift Assay. Domain start/stop: P24-E144	B	CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OCC2CCCN(C)C2)C1		CHEMBL3906203	=	Delta TM	C	2.27	CHEMBL1795186	Homo sapiens	Delta TM	C	2.27
	22069322	CHEMBL4650073	Thermal Shift Assay. Domain start/stop: P24-E144	B	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl		CHEMBL3622373	=	Delta TM	C	1.83	CHEMBL1795186	Homo sapiens	Delta TM	C	1.83
	22069323	CHEMBL4650073	Thermal Shift Assay. Domain start/stop: P24-E144	B	O=C(C=CN1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O		CHEMBL4650213	=	Delta TM	C	0.14	CHEMBL1795186	Homo sapiens	Delta TM	C	0.14
	22069324	CHEMBL4650073	Thermal Shift Assay. Domain start/stop: P24-E144	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta TM	C	5.24	CHEMBL1795186	Homo sapiens	Delta TM	C	5.24
	22069325	CHEMBL4650076	Thermal Shift Assay. Domain start/stop: G306-P416	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Delta TM	C	6.53	CHEMBL1795186	Homo sapiens	Delta TM	C	6.53
	22069326	CHEMBL4650076	Thermal Shift Assay. Domain start/stop: G306-P416	B	CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OCC2CCCN(C)C2)C1		CHEMBL3906203	=	Delta TM	C	1.27	CHEMBL1795186	Homo sapiens	Delta TM	C	1.27
	22069327	CHEMBL4650076	Thermal Shift Assay. Domain start/stop: G306-P416	B	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl		CHEMBL3622373	=	Delta TM	C	1.25	CHEMBL1795186	Homo sapiens	Delta TM	C	1.25
	22069328	CHEMBL4650076	Thermal Shift Assay. Domain start/stop: G306-P416	B	O=C(C=CN1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O		CHEMBL4650213	=	Delta TM	C	0.84	CHEMBL1795186	Homo sapiens	Delta TM	C	0.84
	22069329	CHEMBL4650076	Thermal Shift Assay. Domain start/stop: G306-P416	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta TM	C	5.45	CHEMBL1795186	Homo sapiens	Delta TM	C	5.45
	22069330	CHEMBL4650077	Thermal Shift Assay. Domain start/stop: G306-P416	B	COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C		CHEMBL3752151	=	Delta TM	C	0.83	CHEMBL1795186	Homo sapiens	Delta TM	C	0.83
	22069331	CHEMBL4650077	Thermal Shift Assay. Domain start/stop: G306-P416	B	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C		CHEMBL3770173	=	Delta TM	C	1.93	CHEMBL1795186	Homo sapiens	Delta TM	C	1.93
	22069332	CHEMBL4650077	Thermal Shift Assay. Domain start/stop: G306-P416	B	Cc1cc(=O)n(C)c2cc(N3C(=O)CC[C@@H](NS(=O)(=O)CC(C)C)[C@@H]3c3ccc(Cl)cc3)ccc12		CHEMBL4650212	=	Delta TM	C	0.15	CHEMBL1795186	Homo sapiens	Delta TM	C	0.15
	22069333	CHEMBL4650077	Thermal Shift Assay. Domain start/stop: G306-P416	B	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1		CHEMBL3785432	=	Delta TM	C	0.35	CHEMBL1795186	Homo sapiens	Delta TM	C	0.35
	22069334	CHEMBL4650077	Thermal Shift Assay. Domain start/stop: G306-P416	B	CCn1cc(-c2cccc(C(F)(F)F)c2)c2sc(C(=N)NC3CCS(=O)(=O)CC3)cc2c1=O		CHEMBL3769507	=	Delta TM	C	2.77	CHEMBL1795186	Homo sapiens	Delta TM	C	2.77
	22069335	CHEMBL4650077	Thermal Shift Assay. Domain start/stop: G306-P416	B	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(C)c(=O)n2C		CHEMBL3356143	=	Delta TM	C	0.33	CHEMBL1795186	Homo sapiens	Delta TM	C	0.33
	22069336	CHEMBL4650077	Thermal Shift Assay. Domain start/stop: G306-P416	B	Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12		CHEMBL4570969	=	Delta TM	C	0.13	CHEMBL1795186	Homo sapiens	Delta TM	C	0.13
	22069337	CHEMBL4650077	Thermal Shift Assay. Domain start/stop: G306-P416	B	CC(=O)c1cc(-c2cc(C(=O)NC3CC3)ccc2C)c2ncccn12		CHEMBL4065619	=	Delta TM	C	1.01	CHEMBL1795186	Homo sapiens	Delta TM	C	1.01
	22069338	CHEMBL4650077	Thermal Shift Assay. Domain start/stop: G306-P416	B	Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1		CHEMBL4296718	=	Delta TM	C	-0.07	CHEMBL1795186	Homo sapiens	Delta TM	C	-0.07
	22069339	CHEMBL4650079	Thermal Shift Assay. Domain start/stop: G306-E421	B	COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C		CHEMBL3752151	=	Delta TM	C	0.17	CHEMBL1795186	Homo sapiens	Delta TM	C	0.17
	22069340	CHEMBL4650079	Thermal Shift Assay. Domain start/stop: G306-E421	B	COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C		CHEMBL3752151	=	Delta TM	C	0.17	CHEMBL1795186	Homo sapiens	Delta TM	C	0.17
	22069341	CHEMBL4650079	Thermal Shift Assay. Domain start/stop: G306-E421	B	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C		CHEMBL3770173	=	Delta TM	C	2.03	CHEMBL1795186	Homo sapiens	Delta TM	C	2.03
	22069342	CHEMBL4650079	Thermal Shift Assay. Domain start/stop: G306-E421	B	Cc1cc(=O)n(C)c2cc(N3C(=O)CC[C@@H](NS(=O)(=O)CC(C)C)[C@@H]3c3ccc(Cl)cc3)ccc12		CHEMBL4650212	=	Delta TM	C	-0.26	CHEMBL1795186	Homo sapiens	Delta TM	C	-0.26
	22069343	CHEMBL4650079	Thermal Shift Assay. Domain start/stop: G306-E421	B	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1		CHEMBL3785432	=	Delta TM	C	0.37	CHEMBL1795186	Homo sapiens	Delta TM	C	0.37
	22069344	CHEMBL4650079	Thermal Shift Assay. Domain start/stop: G306-E421	B	CCn1cc(-c2cccc(C(F)(F)F)c2)c2sc(C(=N)NC3CCS(=O)(=O)CC3)cc2c1=O		CHEMBL3769507	=	Delta TM	C	1.79	CHEMBL1795186	Homo sapiens	Delta TM	C	1.79
	22069345	CHEMBL4650079	Thermal Shift Assay. Domain start/stop: G306-E421	B	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(C)c(=O)n2C		CHEMBL3356143	=	Delta TM	C	0.74	CHEMBL1795186	Homo sapiens	Delta TM	C	0.74
	22069346	CHEMBL4650079	Thermal Shift Assay. Domain start/stop: G306-E421	B	Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12		CHEMBL4570969	=	Delta TM	C	0.26	CHEMBL1795186	Homo sapiens	Delta TM	C	0.26
	22069347	CHEMBL4650079	Thermal Shift Assay. Domain start/stop: G306-E421	B	CC(=O)c1cc(-c2cc(C(=O)NC3CC3)ccc2C)c2ncccn12		CHEMBL4065619	=	Delta TM	C	0.91	CHEMBL1795186	Homo sapiens	Delta TM	C	0.91
	22069348	CHEMBL4650079	Thermal Shift Assay. Domain start/stop: G306-E421	B	Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1		CHEMBL4296718	=	Delta TM	C	0.05	CHEMBL1795186	Homo sapiens	Delta TM	C	0.05
	22069349	CHEMBL4650074	Thermal Shift Assay. Domain start/stop: P24-E144	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Delta TM	C	5.42	CHEMBL1795186	Homo sapiens	Delta TM	C	5.42
	22069350	CHEMBL4650078	Thermal Shift Assay. Domain start/stop: G306-P416	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Delta TM	C	7.37	CHEMBL1795186	Homo sapiens	Delta TM	C	7.37
	22389838	CHEMBL4666850	Binding affinity to human partial length BRD3 (BD1) (P24 to E144 residues) expressed in bacterial expression system by BROMOscan assay	B	Cc1noc(C)c1-c1ccc2nc(-c3cnn(CC(C)(C)O)c3)nc(N3CCOC[C@@H]3c3ccccc3)c2c1		CHEMBL4749664	=	Kd	nM	11.0	CHEMBL1795186	Homo sapiens	Kd	nM	11.0
	22389839	CHEMBL4666851	Binding affinity to human partial length BRD3 (BD1,2) (P24 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	Cc1noc(C)c1-c1ccc2nc(-c3cnn(CC(C)(C)O)c3)nc(N3CCOC[C@@H]3c3ccccc3)c2c1		CHEMBL4749664	=	Kd	nM	29.0	CHEMBL1795186	Homo sapiens	Kd	nM	29.0
	22389840	CHEMBL4666852	Binding affinity to human partial length BRD3 (BD2) (G306 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	Cc1noc(C)c1-c1ccc2nc(-c3cnn(CC(C)(C)O)c3)nc(N3CCOC[C@@H]3c3ccccc3)c2c1		CHEMBL4749664	=	Kd	nM	44.0	CHEMBL1795186	Homo sapiens	Kd	nM	44.0
	22397744	CHEMBL4668942	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD3 BD1/BD2 Y348A mutant (1 to 435 residues) (unknown origin) measured after 30 mins by TR-FRET assay	A	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881	=	IC50	nM	39810.72	CHEMBL1795186	Homo sapiens	pIC50		4.4
	22397745	CHEMBL4668943	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD3 BD2/BD1 Y73A mutant (1 to 435 residues) (unknown origin) measured after 30 mins by TR-FRET assay	A	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881	=	IC50	nM	100.0	CHEMBL1795186	Homo sapiens	pIC50		7.0
	22823582	CHEMBL4716997	Inhibition of BRD3 BD1 (unknown origin) using biotinylated JQ1 analog as substrate measured after 20 mins by AlphaLISA assay	B	Cc1nnc2n1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)C[C@H]2C		CHEMBL4780530	=	IC50	nM	3.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.003
	22823583	CHEMBL4716998	Inhibition of BRD3 BD2 (unknown origin) using biotinylated JQ1 analog as substrate measured after 20 mins by AlphaLISA assay	B	Cc1nnc2n1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)C[C@H]2C		CHEMBL4780530	=	IC50	nM	3.0	CHEMBL1795186	Homo sapiens	IC50	uM	0.003
	22856023	CHEMBL4724820	Binding affinity to human partial length BRD3-BD1 (P24 to E144 residues) expressed in bacterial expression system by BROMOscan method	B	CN1C(=O)c2c(F)cccc2Oc2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4763016	=	Kd	nM	52.0	CHEMBL1795186	Homo sapiens	Kd	nM	52.0
	22856024	CHEMBL4724820	Binding affinity to human partial length BRD3-BD1 (P24 to E144 residues) expressed in bacterial expression system by BROMOscan method	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	22.0	CHEMBL1795186	Homo sapiens	Kd	nM	22.0
	22856089	CHEMBL4724832	Binding affinity to human partial length BRD3-BD2 (G306 to P416 residues) expressed in bacterial expression system by BROMOscan method	B	CN1C(=O)c2c(F)cccc2Oc2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4763016	=	Kd	nM	140.0	CHEMBL1795186	Homo sapiens	Kd	nM	140.0
	22856090	CHEMBL4724832	Binding affinity to human partial length BRD3-BD2 (G306 to P416 residues) expressed in bacterial expression system by BROMOscan method	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	23.0	CHEMBL1795186	Homo sapiens	Kd	nM	23.0
	22880738	CHEMBL4727029	Binding affinity to full length BRD3 BD2 in human HuT78 cell lysates incubated for 45 mins by liquid chromatography-mass spectrometry based chemoproteomic binding assay	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362	=	Kd	nM	6309.57	CHEMBL1795186	Homo sapiens	pKd		5.2
	22880920	CHEMBL4727052	Binding affinity to human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in bacterial expression system by BROMOscan assay	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362	=	Kd	nM	15.85	CHEMBL1795186	Homo sapiens	pKd		7.8
	22880924	CHEMBL4727056	Binding affinity to human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362	=	Kd	nM	19952.62	CHEMBL1795186	Homo sapiens	pKd		4.7
	22880933	CHEMBL4727065	Binding affinity to full length BRD3 BD1 in human HuT78 cell lysates incubated for 45 mins by liquid chromatography-mass spectrometry based chemoproteomic binding assay	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362	=	Kd	nM	3.981	CHEMBL1795186	Homo sapiens	pKd		8.4
	22953226	CHEMBL4767051	Binding affinity to human recombinant His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as change in melting temperature at 200 uM incubated for 30 mins by SYPRO orange dye based thermal shift assay	B	COc1cc2onc(C)c2cc1NS(=O)(=O)c1cc(Br)ccc1OC		CHEMBL4798044	=	Delta Tm	degrees C	8.1	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.1
	22953227	CHEMBL4767051	Binding affinity to human recombinant His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as change in melting temperature at 200 uM incubated for 30 mins by SYPRO orange dye based thermal shift assay	B	CNc1cc2onc(C)c2cc1NS(=O)(=O)c1cc(Br)ccc1OC		CHEMBL4781472	=	Delta Tm	degrees C	6.5	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	6.5
	22953228	CHEMBL4767051	Binding affinity to human recombinant His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as change in melting temperature at 200 uM incubated for 30 mins by SYPRO orange dye based thermal shift assay	B	Cc1noc2c(Br)cc(-c3nc4ccc(N5CCOCC5)cc4n3CC3CCCCC3)cc12		CHEMBL4782221	=	Delta Tm	degrees C	8.9	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.9
	22953229	CHEMBL4767051	Binding affinity to human recombinant His6-tagged BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as change in melting temperature at 200 uM incubated for 30 mins by SYPRO orange dye based thermal shift assay	B	Cc1noc2ccc(-c3nc4ccc(N5CCOC[C@@H]5C)cc4n3CC3CCCCC3)cc12		CHEMBL4791634	=	Delta Tm	degrees C	8.7	CHEMBL1795186	Homo sapiens	deltaTm	degrees C	8.7
	23148628	CHEMBL4809928	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD3 BD1/BD2 Y348A mutant (1 to 435 residues) (unknown origin) measured after 30 mins by TR-FRET assay	A	CNC(=O)c1cc(C(=O)N[C@H]2C[C@@H]2C)cc(C(O)c2ccccc2)n1		CHEMBL4862372	=	IC50	nM	39810.72	CHEMBL1795186	Homo sapiens	pIC50		4.4
	23148629	CHEMBL4809929	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD3 BD2/BD1 Y73A mutant (1 to 435 residues) (unknown origin) measured after 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@H]2C[C@@H]2C)cc(C(O)c2ccccc2)n1		CHEMBL4862372	=	IC50	nM	10.0	CHEMBL1795186	Homo sapiens	pIC50		8.0
	23148637	CHEMBL4809937	Binding affinity to human partial length BRD3 BD 1 (P24 to E144 residues) expressed in bacterial expression system by BROMOscan assay	A	CNC(=O)c1cc(C(=O)N[C@H]2C[C@@H]2C)cc(C(O)c2ccccc2)n1		CHEMBL4862372	=	Kd	nM	6309.57	CHEMBL1795186	Homo sapiens	pKd		5.2
	23148638	CHEMBL4809938	Binding affinity to human partial length BRD3 BD 2 (G306 to P416 residues) expressed in bacterial expression system by BROMOscan assay	B	CNC(=O)c1cc(C(=O)N[C@H]2C[C@@H]2C)cc(C(O)c2ccccc2)n1		CHEMBL4862372	=	Kd	nM	5.012	CHEMBL1795186	Homo sapiens	pKd		8.3
	23233277	CHEMBL4827444	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD3 BD1/BD2 Y348A mutant (1 to 435 residues) (unknown origin) measured after 30 mins by TR-FRET assay	B	CNC(=O)CN(CC(c1ccccc1)c1ccccc1)C(=O)c1cc(C)c(OC)c(C)c1		CHEMBL4878540	=	IC50	nM	25118.86	CHEMBL1795186	Homo sapiens	pIC50		4.6
	23233278	CHEMBL4827445	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD3 BD2/BD1 Y73A mutant (1 to 435 residues) (unknown origin) measured after 30 mins by TR-FRET assay	B	CNC(=O)CN(CC(c1ccccc1)c1ccccc1)C(=O)c1cc(C)c(OC)c(C)c1		CHEMBL4878540	=	IC50	nM	100.0	CHEMBL1795186	Homo sapiens	pIC50		7.0
	23233446	CHEMBL4827466	Inhibition of human BRD3 BD1 (P24 to E144 residues) expressed in bacterial expression system at 10 uM by DiscoverX assay relative to control	B	CNC(=O)[C@H](C1CCOCC1)N(CC(c1ccccc1)c1ccccn1)C(=O)c1cc(C)c(=O)n(C)c1		CHEMBL4852928	=	Inhibition	%	75.0	CHEMBL1795186	Homo sapiens	INH	%	75.0
	23233450	CHEMBL4827470	Inhibition of human BRD3 BD2 (G306 to P416 residues) expressed in bacterial expression system at 10 uM by DiscoverX assay relative to control	B	CNC(=O)[C@H](C1CCOCC1)N(CC(c1ccccc1)c1ccccn1)C(=O)c1cc(C)c(=O)n(C)c1		CHEMBL4852928	>=	Inhibition	%	99.8	CHEMBL1795186	Homo sapiens	INH	%	99.8
	23269676	CHEMBL4835105	Inhibition of 6His-Thr-BRD3 (1 to 435 residues) BD2 domain Y348A or Y73A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	CCNC(=O)c1ccc(OCc2cccc(C)n2)c(-c2cn(C)nn2)c1		CHEMBL4856289	=	IC50	nM	316.23	CHEMBL1795186	Homo sapiens	pIC50		6.5
	23269677	CHEMBL4835105	Inhibition of 6His-Thr-BRD3 (1 to 435 residues) BD2 domain Y348A or Y73A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	CCNC(=O)c1cc(Cc2cccc3[nH]ccc23)nc(-c2cn(C)nn2)c1		CHEMBL4856853	=	IC50	nM	31.62	CHEMBL1795186	Homo sapiens	pIC50		7.5
	23269678	CHEMBL4835105	Inhibition of 6His-Thr-BRD3 (1 to 435 residues) BD2 domain Y348A or Y73A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	C[C@H](Oc1ccc(C(=O)NC2CC2)cc1-c1cn(C)nn1)c1ccccn1		CHEMBL4867703	=	IC50	nM	79.43	CHEMBL1795186	Homo sapiens	pIC50		7.1
	23269679	CHEMBL4835106	Inhibition of 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CCNC(=O)c1ccc(OCc2cccc(C)n2)c(-c2cn(C)nn2)c1		CHEMBL4856289	=	IC50	nM	50118.72	CHEMBL1795186	Homo sapiens	pIC50		4.3
	23269680	CHEMBL4835106	Inhibition of 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CCNC(=O)c1cc(Cc2cccc3[nH]ccc23)nc(-c2cn(C)nn2)c1		CHEMBL4856853	=	IC50	nM	31622.78	CHEMBL1795186	Homo sapiens	pIC50		4.5
	23269681	CHEMBL4835106	Inhibition of 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	C[C@H](Oc1ccc(C(=O)NC2CC2)cc1-c1cn(C)nn1)c1ccccn1		CHEMBL4867703	=	IC50	nM	12589.25	CHEMBL1795186	Homo sapiens	pIC50		4.9
	23278081	CHEMBL4836563	Binding affinity to 6His-Thr-BRD3 (1 to 435 residues) BD2 domain Y348A or Y73A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@H]2CC[C@H](O)CC2)n([C@@H](C)c2ccccc2)n1		CHEMBL4854042	=	IC50	nM	79.43	CHEMBL1795186	Homo sapiens	pIC50		7.1
	23278082	CHEMBL4836563	Binding affinity to 6His-Thr-BRD3 (1 to 435 residues) BD2 domain Y348A or Y73A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@H]2CC[C@H](O)CC2)c([C@@H](C)c2ccccc2)o1		CHEMBL4865767	=	IC50	nM	31.62	CHEMBL1795186	Homo sapiens	pIC50		7.5
	23278083	CHEMBL4836564	Binding affinity to 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@H]2CC[C@H](O)CC2)n([C@@H](C)c2ccccc2)n1		CHEMBL4854042	=	IC50	nM	25118.86	CHEMBL1795186	Homo sapiens	pIC50		4.6
	23278084	CHEMBL4836564	Binding affinity to 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@H]2CC[C@H](O)CC2)c([C@@H](C)c2ccccc2)o1		CHEMBL4865767	=	IC50	nM	10000.0	CHEMBL1795186	Homo sapiens	pIC50		5.0
	23278290	CHEMBL4836617	Inhibition of recombinant human BRD3 BD2 (306 to 416 residues) expressed in bacterial expression system by bromoscan assay	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3C[C@H](O)C[C@H]32)cc2c1OC[C@@]2(C)c1ccccc1		CHEMBL4869149	=	IC50	nM	1.259	CHEMBL1795186	Homo sapiens	pIC50		8.9
	23278292	CHEMBL4836619	Inhibition of recombinant human BRD3 BD1 (24 to 144 residues) expressed in bacterial expression system by bromoscan assay	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3C[C@H](O)C[C@H]32)cc2c1OC[C@@]2(C)c1ccccc1		CHEMBL4869149	=	IC50	nM	3981.07	CHEMBL1795186	Homo sapiens	pIC50		5.4
	23278299	CHEMBL4836626	Inhibition of 6His-Thr-BRD3 (1 to 435 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3C[C@H](O)C[C@H]32)cc2c1OC[C@@]2(C)c1ccccc1		CHEMBL4869149	=	IC50	nM	31622.78	CHEMBL1795186	Homo sapiens	pIC50		4.5
	23278300	CHEMBL4836627	Inhibition of 6His-Thr-BRD3 (1 to 435 residues) BD2 domain Y348A or Y73A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3C[C@H](O)C[C@H]32)cc2c1OC[C@@]2(C)c1ccccc1		CHEMBL4869149	=	IC50	nM	6.31	CHEMBL1795186	Homo sapiens	pIC50		8.2
Active	23374364	CHEMBL4885667	BET mutant TR-FRETassay (BRD3 BD1)	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		IC50	nM	158.49	CHEMBL1795186	Homo sapiens	pIC50		6.8
Not Active	23374365	CHEMBL4885668	BET mutant TR-FRET assay (BRD3 BD2)	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		IC50	nM	19952.62	CHEMBL1795186	Homo sapiens	pIC50		4.7
Active	23374372	CHEMBL4885675	BRD3 BD1 Bromoscan (DiscoverX)	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	15.85	CHEMBL1795186	Homo sapiens	pKd		7.8
Not Active	23374373	CHEMBL4885676	BRD3 BD2 Bromoscan (DiscoverX)	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	19952.62	CHEMBL1795186	Homo sapiens	pKd		4.7
Active	23374380	CHEMBL4885683	BRD3 BD1 Chemoproteomics	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	3.981	CHEMBL1795186	Homo sapiens	pKd		8.4
Not Active	23374381	CHEMBL4885684	BRD3 BD2 Chemoproteomics	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	6309.57	CHEMBL1795186	Homo sapiens	pKd		5.2
	23374400	CHEMBL4885703	BRD3 (BD1) DiscoverX BROMOscan	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	15.85	CHEMBL1795186	Homo sapiens	pKd		7.8
	23374401	CHEMBL4885704	BRD3 (BD2) DiscoverX BROMOscan	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	19952.62	CHEMBL1795186	Homo sapiens	pKd		4.7
Not Active	23374431	CHEMBL4885667	BET mutant TR-FRETassay (BRD3 BD1)	B	Cc1cc2c(-c3ccco3)cnc(N[C@H]3CCN(C)C[C@@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4635540		IC50	nM	3981.07	CHEMBL1795186	Homo sapiens	pIC50		5.4
Not Active	23374432	CHEMBL4885668	BET mutant TR-FRET assay (BRD3 BD2)	B	Cc1cc2c(-c3ccco3)cnc(N[C@H]3CCN(C)C[C@@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4635540		IC50	nM	19952.62	CHEMBL1795186	Homo sapiens	pIC50		4.7
Not Active	23374533	CHEMBL4885734	TR-FRET assay (BRD3 BD1)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		IC50	nM	36317.0	CHEMBL1795186	Homo sapiens	IC50	nM	36317.0
Active	23374534	CHEMBL4885735	TR-FRET assay (BRD3 BD2)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		IC50	nM	98.0	CHEMBL1795186	Homo sapiens	IC50	nM	98.0
Not Active	23374541	CHEMBL4885742	BET mutant TR-FRETassay (BRD3 BD1)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		IC50	nM	39810.72	CHEMBL1795186	Homo sapiens	pIC50		4.4
Active	23374542	CHEMBL4885743	BET mutant TR-FRET assay (BRD3 BD2)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		IC50	nM	100.0	CHEMBL1795186	Homo sapiens	pIC50		7.0
Not Active	23374549	CHEMBL4885750	BRD3 BD1 Bromoscan (DiscoverX)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		Kd	nM	2082.0	CHEMBL1795186	Homo sapiens	Kd	nM	2082.0
Active	23374550	CHEMBL4885751	BRD3 BD2 Bromoscan (DiscoverX)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		Kd	nM	32.0	CHEMBL1795186	Homo sapiens	Kd	nM	32.0
	23374567	CHEMBL4885768	BRD3(1) DiscoverX BROMOscan	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		Kd	nM	2082.0	CHEMBL1795186	Homo sapiens	Kd	nM	2082.0
	23374568	CHEMBL4885769	BRD3(1,2) DiscoverX BROMOscan	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		Kd	nM	47.0	CHEMBL1795186	Homo sapiens	Kd	nM	47.0
	23374569	CHEMBL4885770	BRD3(2) DiscoverX BROMOscan	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		Kd	nM	33.0	CHEMBL1795186	Homo sapiens	Kd	nM	33.0
Not Active	23374648	CHEMBL4885734	TR-FRET assay (BRD3 BD1)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		IC50	nM	25802.0	CHEMBL1795186	Homo sapiens	IC50	nM	25802.0
Active	23374649	CHEMBL4885735	TR-FRET assay (BRD3 BD2)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		IC50	nM	72.0	CHEMBL1795186	Homo sapiens	IC50	nM	72.0
Not Active	23374656	CHEMBL4885802	BET mutant TR-FRETassay (BRD3 BD1)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		IC50	nM	25118.86	CHEMBL1795186	Homo sapiens	pIC50		4.6
Active	23374657	CHEMBL4885803	BET mutant TR-FRET assay (BRD3 BD2)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		IC50	nM	79.43	CHEMBL1795186	Homo sapiens	pIC50		7.1
Not Active	23374664	CHEMBL4885810	BRD3 BD1 Bromoscan (DiscoverX)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		Kd	nM	7943.28	CHEMBL1795186	Homo sapiens	pKd		5.1
Active	23374665	CHEMBL4885811	BRD3 BD2 Bromoscan (DiscoverX)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		Kd	nM	12.59	CHEMBL1795186	Homo sapiens	pKd		7.9
	23374681	CHEMBL4885827	BRD3(1) DiscoverX BROMOscan	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		Kd	nM	7943.28	CHEMBL1795186	Homo sapiens	pKd		5.1
	23374682	CHEMBL4885828	BRD3(2) DiscoverX BROMOscan	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		Kd	nM	12.59	CHEMBL1795186	Homo sapiens	pKd		7.9
Active	23379090	CHEMBL4885734	TR-FRET assay (BRD3 BD1)	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		IC50	nM	41.0	CHEMBL1795186	Homo sapiens	IC50	nM	41.0
Not Active	23379091	CHEMBL4885735	TR-FRET assay (BRD3 BD2)	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		IC50	nM	1210.0	CHEMBL1795186	Homo sapiens	IC50	nM	1210.0
Active	23379098	CHEMBL4886809	BET mutant TR-FRETassay (BRD3 BD1)	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		IC50	nM	39.81	CHEMBL1795186	Homo sapiens	pIC50		7.4
Not Active	23379099	CHEMBL4886810	BET mutant TR-FRET assay (BRD3 BD2)	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		IC50	nM	1000.0	CHEMBL1795186	Homo sapiens	pIC50		6.0
Active	23379105	CHEMBL4886816	BRD3 Bromoscan (DiscoverX)	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		Kd	nM	5.0	CHEMBL1795186	Homo sapiens	Kd	nM	5.0
	23379119	CHEMBL4886830	BRD3(1) DiscoverX BROMOscan	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		Kd	nM	5.0	CHEMBL1795186	Homo sapiens	Kd	nM	5.0
	23379120	CHEMBL4886831	BRD3(2) DiscoverX BROMOscan	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		Kd	nM	310.0	CHEMBL1795186	Homo sapiens	Kd	nM	310.0
Not Active	23379203	CHEMBL4886859	BET mutant TR-FRETassay (BRD3 BD1)	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		IC50	nM	31622.78	CHEMBL1795186	Homo sapiens	pIC50		4.5
Active	23379204	CHEMBL4886860	BET mutant TR-FRET assay (BRD3 BD2)	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		IC50	nM	15.85	CHEMBL1795186	Homo sapiens	pIC50		7.8
Not Active	23379211	CHEMBL4886867	BRD3 BD1 Bromoscan (DiscoverX)	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		Kd	nM	6309.57	CHEMBL1795186	Homo sapiens	pKd		5.2
Active	23379212	CHEMBL4886868	BRD3 BD2 Bromoscan (DiscoverX)	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		Kd	nM	3.162	CHEMBL1795186	Homo sapiens	pKd		8.5
	23379248	CHEMBL4886906	BRD3 (BD1) DiscoverX BROMOscan	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		Kd	nM	6309.57	CHEMBL1795186	Homo sapiens	pKd		5.2
	23379249	CHEMBL4886907	BRD3 (BD2) DiscoverX BROMOscan	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		Kd	nM	3.162	CHEMBL1795186	Homo sapiens	pKd		8.5
